TIDMIII
RNS Number : 0173S
3i Group PLC
11 November 2021
11 November 2021
3i Group plc announces results for the
six months to 30 September 2021
High quality portfolio drives strong result
-- Total return of GBP2,199 million or 24% on opening
shareholders' funds (September 2020: GBP1,142 million, 15%) and NAV
per share of 1,153 pence (31 March 2021: 947 pence) after paying 21
pence second dividend in July 2021.
-- Our Private Equity portfolio continues to perform strongly,
with a gross investment return of GBP2,373 million in the period,
or 27% (September 2020: GBP1,245 million, 19%). The majority of top
20 Private Equity investments demonstrated considerable momentum in
the period, and in particular those in our chosen areas of focus of
value-for-money, e-commerce, consumer and healthcare. These
continue to benefit from our active management and long-term
structural growth trends, some of which were accelerated by the
pandemic.
-- Action continues to surpass expectations. Its growth has
accelerated since the lifting of Covid-related restrictions,
resulting in sales in the nine months to the end of period nine
2021 of EUR4.8 billion, 25% ahead of the same period last year .
Like-for-like sales growth over the same period was also strong at
12.9%, compared to negative 2.5% in the same period last year.
Action delivered last twelve months EBITDA of EUR765 million to the
end of period nine 2021 (September 2020: EUR579 million). Strong
trading continued into October 2021, with sales increasing to
EUR5.4 billion and last twelve months EBITDA of EUR777 million. The
international roll-out is proceeding well and the business is on
track to open about 270 new stores in 2021.
-- In competitive markets for new investment our Private Equity
business has continued to deploy capital selectively , with new
investments in MAIT and the newly created ten23 health platform, as
well as bolt-on investments for Cirtec Medical, Luqom and Havea in
the period. Investment activity has continued since the period end,
with a new investment in Dutch Bakery, transformational bolt-on
acquisitions for GartenHaus and ten23 health and a bolt-on
acquisition for Evernex. We signed the realisation of Magnitude
Software in September 2021, which completed at the start of
November 2021, returning GBP345 million of proceeds to 3i,
representing a 109% uplift on 31 March 2021 value. The sale
achieved a sterling money multiple of 2.5x and sterling IRR of 44%
after a holding period of two and a half years. In November 2021,
we completed a GBP36 million co-investment in insightsoftware, the
company that acquired our investment in Magnitude Software and
announced the partial sale of our stake in Basic-Fit at EUR44.25
per share, generating proceeds of c.GBP146 million.
-- Our Infrastructure business delivered a gross investment
return of GBP60 million, or 5% (September 2020: GBP134 million,
12%). This return was driven by the increase in 3i Infrastructure
plc's share price and dividend income. Our other Infrastructure
investment vehicles and our direct US investments performed in line
with expectations in the period .
-- First FY2022 dividend of 19.25 pence per share , in line with
policy. This will be paid to shareholders in January 2022.
Simon Borrows, 3i's Chief Executive , commented:
" We saw good growth from our two investment portfolios in the
first half of the year and this momentum has continued into
November. 3i is beginning to see a significant compounding effect
from the performance of today's carefully selected Private Equity
portfolio.
Despite the social and economic uncertainty that we have seen
over the last 18 months, competition for private assets remains
very strong. While we will continue to deploy capital selectively
in new and bolt-on investments, we are also in a good position to
benefit from favourable market conditions through our realisation
pipeline to deliver attractive returns for our shareholders."
Summary financial highlights under the Investment basis
3i prepares its statutory financial statements in accordance
with International Financial Reporting Standards as adopted by the
European Union ("IFRS"). However, we also report a non-GAAP
"Investment basis" which we believe aids users of our report to
assess the Group's underlying operating performance. The Investment
basis (which is unaudited) is an alternative performance measure
("APM") and is described in the Reconciliation of the Investment
basis to IFRS section later in this document. Total return and net
assets are the same under the Investment basis and IFRS and we
provide a reconciliation of our Investment basis financial
statements to the IFRS statements from in the Reconciliation of the
Investment basis to IFRS section later in this document . The
content from the beginning of this document up to the Alternative
Performance Measures section is prepared on an Investment
basis.
Six months to/as Six months to/as 12 months to/as
at 30 September at 30 September at 31 March
Investment basis 2021 2020 2021
-------------------------------------------------------------- ----------------- ----------------- ----------------
Total return(1) GBP2,199m GBP1,142m GBP1,726m
% return on opening shareholders' funds 24% 15% 22%
Dividend per ordinary share 19.25p 17.5p 38.5p
============================================================== ================= ================= ================
Gross investment return(2) GBP2,463m GBP1,394m GBP2,139m
As a percentage of opening 3i portfolio value 24% 17% 26%
Cash investment(2) GBP59m GBP233m GBP510m
Realisation proceeds GBP124m GBP82m GBP218m
3i portfolio value GBP12,784m GBP9,578m GBP10,408m
Gross debt GBP975m GBP975m GBP975m
Net (debt) (2) GBP(931)m GBP(288)m GBP(750)m
Gearing(2) 8% 3% 8%
Liquidity GBP544m GBP1,087m GBP725m
Diluted net asset value per ordinary share ("NAV per share") 1,153p 905p 947p
============================================================== ================= ================= ================
1 Total return is defined as Total comprehensive income for the year, under both the Investment
basis and the IFRS basis.
2 Financial measure defined as APM. Further information can be found in the Alternative Performance
Measures section later in this document.
Disclaimer
These half-year results have been prepared solely to provide information to shareholders.
They should not be relied on by any other party or for any other purpose. These half-year
results may contain statements about the future, including certain statements about the future
outlook for 3i Group plc and its subsidiaries ("3i" or "the Group"). These are not guarantees
of future performance and will not be updated. Although we believe our expectations are based
on reasonable assumptions, any statements about the future outlook may be influenced by factors
that could cause actual outcomes and results to be materially different.
Enquiries:
Silvia Santoro, Group Investor Relations Director 020 7975 3258
Kathryn van der Kroft, Communications Director 020 7975 3021
A PDF copy of this release can be downloaded from www.3i.com/investor-relations
For further information, including a live webcast of the results presentation at 10.00am on
11 November 2021, please visit www.3i.com/investor-relations
3i Group Half-year report 2021
Chief Executive's review
Our first half performance was very strong, reflecting the
quality of our portfolio and the broader market recovery. We
generated a total return of GBP2,199 million, or 24% on opening
shareholders' funds (September 2020: GBP1,142 million, or 15%) .
Our Private Equity and Infrastructure investment teams were very
active in the period, deploying capital across new, further, and
bolt-on investments whilst also achieving attractive returns from
two divestments signed in the period. NAV per share at 30 September
2021 was 1,153 pence (31 March 2021: 947 pence), after the payment
of the 21 pence second FY2021 dividend in July 2021.
Private Equity
The Private Equity portfolio continued to perform strongly,
generating a gross investment return ("GIR") of 27% in the first
half. The majority of our top 20 Private Equity assets demonstrated
considerable momentum in the period, with those operating in our
chosen areas of focus (value-for-money, e-commerce, consumer and
healthcare) continuing to benefit from our active management and
long-term secular growth trends. We have continued to work with our
portfolio companies to adapt quickly and respond effectively to the
pandemic and its aftermath including disruption to global supply
chains and inflationary and labour market pressures.
Action performance
Action continues to deliver results ahead of the expectations we
set for its five-year plan in 2019. With the easing of restrictions
in Q2 and Q3 2021 and the reopening of all stores, Action's growth
has accelerated, resulting in sales in the nine months to the end
of period nine ("P9") 2021 of EUR4.8 billion, 25% ahead of the same
period last year. Like-for-like ("LFL") sales growth over the same
period was also impressive at 12.9%, compared to negative 2.5% in
the equivalent period in 2020, which was significantly impacted by
Covid-19. Action delivered last twelve months ("LTM") EBITDA of
EUR765 million to the end of P9 2021 (September 2020: EUR579
million). This strong momentum continued into October 2021, with
sales increasing to EUR5.4 billion and LTM EBITDA of EUR777
million. Action has not been immune from disruptions in global
supply chains and inflationary pressures in product, labour and
transport costs. However, as a large business with 14 categories, a
diverse supplier base and significant buying power, Action has been
able to continue purchasing stock throughout the pandemic and is
better placed than many retailers to manage these pressures while
continuing to grow sales and profits.
Action's store expansion has ramped up in 2021, following a
slower roll-out in the first half of 2020 due to Covid-19. In the
year to date, Action opened 181 new stores and is on track to open
about 270 stores in 2021. Action continues to grow its
international footprint. Its five pilot stores in Italy are
performing strongly, supporting the decision to roll-out in that
country with the next two stores being opened this month. The
roll-out in the Czech Republic is also proceeding at a high pace
following a successful pilot in 2020. Action remains highly cash
generative, with a current cash balance of over EUR1 billion. As
announced on 2 November 2021, Action appointed Hajir Hajji,
currently Action's Commercial Director and member of the Action
executive management team, to succeed Sander van der Laan as CEO.
Hajir will formally become CEO of Action on 1 January 2022.
Other portfolio performance and activity in the period
BoConcept has performed strongly in the last year with record
order levels. Luqom continues to benefit from the structural shift
in demand to online channels, whilst Hans Anders has seen a good
uptick in footfall and order intake as a result of easing
restrictions and increased consumer focus on value for money.
SaniSure, the bio-processing platform, is performing well,
benefitting from an acceleration in its key biologics and
single-use markets. It was able to return GBP59 million of 3i's
original investment in the period. Royal Sanders remained highly
cash generative and, following a refinancing, returned cash of
GBP84 million to 3i. Good momentum at Basic-Fit following the
reopening of all clubs resulted in a 20% increase in the share
price between 31 March 2021 and 30 September 2021 , whilst Tato and
AES continue to perform well and generated dividend income for 3i
in the period.
Q Holding's electrical connector seal business has benefitted
from substantial demand. Its medical business has also performed
well due to a rebound in medical procedures tied to its key
products and geographies. Cirtec Medical continues to enhance its
platform value, with recent M&A activity accelerating its
diversification into the minimally invasive therapeutic device
space and broadening the suite of high value capabilities that are
now driving an attractive new product pipeline. Our more recent
investment in GartenHaus has demonstrated good growth levels
despite raw material price increases and supply chain challenges,
whilst MPM has benefitted from the increase in pet ownership over
the last 18 months and customer account wins, particularly in the
US.
Audley Travel and arrivia continue to operate in a leisure
travel end market which is recovering but still subject to evolving
government restrictions. In October 2021, we invested a further
GBP25 million in Audley Travel to support the business as it
recovers from the pandemic. Delayed production launches and
contracting volumes in the automotive sector, coupled with
semi-conductor shortages and operational challenges, continue to
impact the performance of Formel D.
Since the start of our financial year, Private Equity markets
have continued to rally with a surge in both volume and value of
buyout deal activity fuelled by record levels of uninvested
capital. As a result, private company valuations continue to
increase. In this context, it is very important that we maintain
our price discipline and that we deploy capital selectively,
building value through international roll-outs or bolt-on
acquisitions. We invested GBP56 million in MAIT, a provider of
digital solutions in the DACH region. We also adopted an innovative
approach in forming a new platform, ten23 health, to create a
contract development and manufacturing organisation ("CDMO"), which
provides an integrated offering for sterile drug product
development and manufacturing of biologics, challenging molecules
and dosage forms . We also completed one bolt-on acquisition for
each of Cirtec Medical, Luqom and Havea. Since our original
investment, we have completed multiple bolt-on acquisitions for
each of these companies, expanding their international footprint,
diversifying their product offering and generating significant
synergies.
We have a busy investment pipeline. Since the period end, in
October 2021, we invested GBP46 million in Dutch Bakery, an
industrial bakery group specialised in home-baked bread and snack
products, which we intend to grow both organically and through a
targeted buy-and-build strategy. We also completed transformational
bolt-on acquisitions for GartenHaus with the acquisition of Outdoor
Toys, a UK-based online retailer of outdoor garden toys, investing
GBP47 million of 3i proprietary capital, and for ten23 health,
investing GBP62 million to support growth initiatives, including
the scale up and expansion of the Basel formulation and drug
development operations, as well as the acquisition of Swissfillon,
a drug product fill and finish CDMO. The total 3i investment in the
ten23 health platform is now GBP69 million. In November 2021, we
announced Evernex's bolt-on acquisition of Emcon-IT, a leading
player in the third party hardware maintenance industry.
We signalled in our FY2021 annual results announcement that we
expected FY2022 to be busier than the preceding year for
realisations, and at the start of November 2021 we completed the
sale of Magnitude Software, returning GBP345 million of proceeds to
3i, representing a 109% uplift on 31 March 2021 value. The sale
achieved a sterling money multiple of 2.5x and sterling IRR of 44%,
an exceptional return after a holding period of only two and a half
years. During this period, 3i supported several new product
launches, the transition from on-premises to cloud software
solutions and investments in sales and marketing which have
increased Magnitude Software's organic growth rate. In November
2021, we completed a GBP36 million co-investment in
insightsoftware, the company that acquired our investment in
Magnitude Software and announced the partial sale of our stake in
Basic-Fit at EUR44.25 per share, generating proceeds of c.GBP146
million. We have a good pipeline of realisations and distributions
which we expect will crystallise in the second half of this
financial year.
Infrastructure
In the six months to 30 September 2021 our Infrastructure
business delivered a GIR of 5%, predominantly driven by a 3%
increase in the 3i Infrastructure plc ("3iN") share price to 304
pence at 30 September 2021 (March 2021: 296 pence) and good
dividend income.
3iN generated a total return on opening NAV of 10.6% in the six
months to 30 September 2021 driven by strong portfolio performance.
3iN's investment pipeline remains busy and during the period it
completed its new investment in DNS:NET, as well as a bolt-on
acquisition for its existing portfolio company Joulz. The business
also announced the realisation of Oystercatcher's four European
terminals driving an uplift of 69% to its 31 March 2021 value.
Oystercatcher retained a 45% stake in Oiltanking Singapore Limited.
Oystercatcher's unrealised money multiple is now 3.0x and
unrealised IRR is 13.9% over 3iN's 14-year investment period. 3iN
is on track to deliver its dividend target of 10.45 pence per
share, which is up 6.6% on last year.
Both of our US infrastructure assets performed in line with
expectations in the period. As the US continues to recover from the
pandemic, Smarte Carte has seen increased demand in its airport
service offering. Regional Rail, which delivers essential freight
services, has continued to see good performance.
Scandlines
Scandlines performed well in the period. While freight volumes
have remained stable throughout the pandemic, leisure travel and
shopping ticket volumes increased as travel restrictions eased
between Denmark, Scandinavia and Germany over the summer.
Balance sheet and dividend
At 30 September 2021 we had total liquidity of GBP544 million
(31 March 2021: GBP725 million) , including our GBP500 million
undrawn RCF. Net debt was GBP931 million, and gearing was 8% (31
March 2021: GBP750 million net debt, gearing 8%) .
In line with our dividend policy, we have decided to pay a first
FY2022 dividend of 19.25 pence, which is half of our FY2021 total
dividend. This first FY2022 dividend will be paid to shareholders
on 12 January 2022.
Board and people update
Throughout this pandemic, our focus has been on protecting the
wellbeing of our own employees, as well as those of our portfolio
companies and the communities in which we collectively operate. All
offices are now open, and it has been good to work with colleagues
in the office environment again.
As announced on 30 September 2021, David Hutchison will become
non-executive Chairman of the Board on the announcement of these
half-year results on 11 November 2021. He will succeed Simon
Thompson who will step down from the Board at the same time. I am
grateful to Simon for his leadership of the 3i Board, particularly
through the Covid-19 pandemic. The Board also appointed Lesley Knox
as non-executive Director as of 1 October 2021.
Outlook
We saw good growth from our two investment portfolios in the
first half of the year and this momentum has continued into
November. 3i is beginning to see a significant compounding effect
from the performance of today's carefully selected Private Equity
portfolio.
Despite the social and economic uncertainty that we have seen
over the last 18 months, competition for private assets remains
very strong. While we will continue to deploy capital selectively
in new and bolt-on investments, we are also in a good position to
benefit from favourable market conditions through our realisation
pipeline to deliver attractive returns for our shareholders.
Simon Borrows
Chief Executive
10 November 2021
Business and Financial review
Private Equity
Our Private Equity business delivered a very strong return in
the first half, generating a GIR of GBP2,373 million (September
2020: GBP1,245 million), or 27% of the opening portfolio value
(September 2020: 19%).
Table 1: Gross investment return for the six months to 30
September
2021 2020
Investment basis GBPm GBPm
============================================================ ====== ======
Realised profits over value on the disposal of investments 12 3
Unrealised profits on the revaluation of investments 2,219 1,071
Dividends 10 43
Interest income from investment portfolio 33 25
Fees receivable 2 6
Foreign exchange on investments 97 97
Gross investment return 2,373 1,245
============================================================ ====== ======
Gross investment return as a % of opening portfolio value 27% 19%
============================================================ ====== ======
Investment
Table 2: Private Equity cash investment in the six months to 30
September 2021
Proprietary
capital
investment
Investment Type Business description/bolt on description Date GBPm
============= ================== ===================================================== =============== ===========
ten23 health Initial Drug product CDMO May 2021 7
Luqom Further Online lighting specialist retailer July 2021 57
MAIT New Provider of digital solutions in the DACH region September 2021 56
Total Private Equity new and further cash investment 120
--------------------------------------------------------------------------------------------------------- -----------
Global provider of recruitment process outsourcing
and other
WilsonHCG Return of funding talent solutions May 2021 (3)
Manufacturer, distributor and integrator of
SaniSure Return of funding single-use bioprocessing systems and components July 2021 (59)
------------- ------------------ ----------------------------------------------------- --------------- -----------
Total Private Equity return of funding (62)
========================================================================================================= ===========
Total Private Equity cash net investment 58
========================================================================================================= ===========
Table 3: Private Equity portfolio bolt-on acquisitions - funded
by the portfolio company
in the six months to 30 September 2021
Asset Name of acquisition Business description of bolt-on investments Date
-------------- --------------------------- --------------------------------------------------------- --------------
Luqom Lampemesteren Online retailer of premium lighting products in the April 2021
Nordic region
-------------- --------------------------- --------------------------------------------------------- --------------
Cirtec Medical Cardea Catheter Innovations Contract manufacturer specialising in the design and July 2021
development of catheter systems
-------------- --------------------------- --------------------------------------------------------- --------------
Havea ixX Pharma Independent player in the Belgian premium food supplement September 2021
segment
-------------- --------------------------- --------------------------------------------------------- --------------
In the period, we invested GBP56 million in MAIT, an attractive
platform in the software sector, with several strategic acquisition
opportunities in a highly fragmented market. We provided initial
capital to ten23 health in May 2021, creating a pure-play,
patient-centric and sustainable biologics drug product CDMO focused
on helping innovative biotech and pharma customers develop and
commercialise injectable biopharmaceutical drugs. We will grow the
ten23 health platform both organically and through
acquisitions.
In July 2021, we invested a further GBP57 million in Luqom,
which was primarily for the purchase of a minority holding. As a
result of a refinancing, and within 12 months of our investment in
Sani-Tech West, SaniSure returned GBP59 million of 3i's proprietary
capital. Similarly, WilsonHCG returned GBP3 million of
overfunding.
We also continued to originate acquisition opportunities for our
portfolio companies, as shown in table 3. All three of these
bolt-on acquisitions were funded by the portfolio companies and
represent Luqom's second, Cirtec Medical's eighth and Havea's fifth
bolt-on acquisition since our original investment.
Since the period end, in October 2021, we invested GBP46 million
in Dutch Bakery, an industrial bakery group specialised in home
bake-off bread and snack products. We completed transformational
bolt-on acquisitions for GartenHaus with the acquisition of Outdoor
Toys, a UK-based online retailer of outdoor garden toys, investing
GBP47 million of 3i proprietary capital, and for ten23 health,
investing GBP 62 million to support growth initiatives, including
the scale up and expansion of the Basel formulation and drug
development operations, as well as the acquisition of Swissfillon,
a drug product fill and finish CDMO. The total 3i investment in the
ten23 health platform is now GBP69 million. In November 2021, we
completed a GBP36 million co-investment in insightsoftware the
company that acquired our investment in Magnitude Software and
announced Evernex's bolt-on acquisition of Emcon-IT, a leading
player in the third-party hardware maintenance industry.
Realisations
We recognised total realised proceeds of GBP118 million in the
period (September 2020: GBP82 million). These comprise GBP84
million of refinancing proceeds from Royal Sanders, of which GBP4
million was recorded as income, and GBP17 million of proceeds from
BoConcept following a partial repayment of a shareholder loan.
Furthermore, we generated proceeds of GBP21 million from our legacy
portfolio.
In September 2021, we agreed the sale of Magnitude Software for
proceeds of GBP345 million, which were received in November 2021,
realising a sterling money multiple of 2.5x and sterling IRR of 44%
in the two and a half years since our initial investment.
Table 4: Private Equity realisations in the six months to 30
September 2021
31 March Uplift on
Calendar 2021 3i realised Profit opening Residual
year value (1) proceeds in the year (2) Value (2) value
Investment Country invested GBPm GBPm GBPm % GBPm
======================== ============= ========== ========== ============ ================ ========== =========
Refinancing
Royal Sanders Netherlands 2018 80 80 - - 295
======================== ============= ========== ========== ============ ================ ========== =========
Full realisations
Other n/a n/a 1 2 1 100% -
======================== ============= ========== ========== ============ ================ ========== =========
Partial realisations
BoConcept Denmark 2016 17 17 - - 240
Other n/a n/a n/a 8 - - n/a
Deferred consideration
Eltel Nordic 2007 - 10 10 - -
Other n/a n/a n/a 1 1 - n/a
======================== ============= ========== ========== ============ ================ ========== =========
Total Private Equity realisations 98 118 12 - 535
=================================================== ========== ============ ================ ========== =========
1 For partial realisations and refinancings, 31 March 2021 value represents
value of stake sold or refinanced.
2 Cash proceeds realised in the period over opening value.
Portfolio performance
Table 5: Unrealised profits/(losses) on the revaluation of
Private Equity investments(1) in the six months to 30 September
2021 2020
GBPm GBPm
=============================================== ====== ======
Action
Performance 1,491 644
Earnings based valuations (excluding Action)
Performance 354 238
Multiple movements 162 211
Other bases
Discounted cash flow ("DCF") 1 (60)
Other movements in unquoted investments - (1)
Imminent sale 166 11
Quoted portfolio 45 28
============================================== ====== ======
Total 2,219 1,071
=============================================== ====== ======
1 More information on our valuation methodology, including definitions and rationale, is included
in our Annual report and accounts 2021 on pages 188 to 189.
Action valuation and performance
In the nine months to the end of P9 2021, Action delivered very
strong earnings growth and cash generation and continued its
international store roll-out. This was reflected in the GBP1,491
million (September 2020: GBP644 million) unrealised profits shown
in Table 5. As the largest Private Equity investment by value, it
represented 55% of the Private Equity portfolio (31 March 2021:
52%). Further information on Action's performance in the period is
provided in the CEO statement.
At 30 September 2021, Action was valued using its LTM run-rate
earnings to the end of P9 2021 of EUR845 million. The LTM run-rate
earnings used include our normal adjustment to reflect stores
opened in the year, as well as the add back of EUR10 million of
exceptional Covid-19 related costs incurred in Action's first
quarter of 2021 and a EUR7 million adjustment for the 53(rd) week
recognised in 2020. At 30 September 2021, Action was valued on a
multiple of 18.5x net of the liquidity discount (31 March 2021:
18.5x). This resulted in a valuation of our 52.7% stake in Action
of GBP6,100 million (31 March 2021: GBP4,566 million).
Performance (excluding Action)
Our top 20 assets, excluding Action, generated good unrealised
profits in the period. BoConcept continues to trade strongly on the
back of operational improvements implemented since our initial
investment. The business has benefitted from increased spending on
the home in some countries and, despite continued retail closures
in other geographies, sales in the first five months of its fiscal
year to April 2022 increased by more than 20% on the prior year.
Luqom has continued to benefit from the structural shift to online
shopping and increased consumer focus on the home and living
category. Encouragingly, despite the lifting of restrictions
enabling shoppers to visit competitors' physical stores, the
company has continued to grow revenue and outpace its peers' growth
rates. In addition to completing the bolt-on acquisition of
Lampemesteren, the business has further internationalised its
footprint with QLF, a company it acquired in 2019, launching a
further ten webshops in Southern and Eastern Europe since the
beginning of 2021. GartenHaus, which also operates in the
e-commerce space, has benefitted from similar market trends. The
company's proactive supplier management and pricing strategies
enabled the business to grow earnings despite raw material price
increases and longer delivery times. Hans Anders performed
resiliently through the first quarter of 2021 despite significant
Covid-19 restrictions. Following the easing of restrictions in the
second quarter of 2021, the business has seen an increase in
footfall and purchases, with particularly strong performance in the
Netherlands and Belgium. The business is also benefitting from its
successful omni-channel strategy and increased operational
efficiency since the onset of the pandemic. Royal Sanders has seen
a more normalised level of demand for hand gels and hand wash in
the six months to the end of September 2021 and is addressing
industry wide raw material price inflation with pricing strategies
and new account wins.
The majority of our UK portfolio performed well in the period.
Tato has maintained good momentum into 2021, following a
combination of sustained demand for its core biocides products and
strong supply levels through the pandemic from its global platform.
The business returned dividend income of GBP4 million to 3i in the
period. AES has remained resilient throughout the pandemic and has
continued to grow earnings as a result of increased sales volumes
and operational efficiencies. MPM has benefitted from the
pandemic-related increase in pet ownership over the last 18 months.
This step change increase in new pet households represents a
significant and lasting source of demand for pet care products and
services across all regions.
Our healthcare sector investments continue to generate good
returns. SaniSure is benefitting from strong momentum in the
biologics and single-use markets, and generated record levels of
new orders in the first six months of 2021. The business continues
to ramp up its capacity to meet the fast-growing demand, while in
parallel working to commercialise innovative new solutions. Q
Holding's medical device business is seeing good growth due to a
strong rebound in procedure volumes in its core markets, including
emerging markets that were particularly impacted in 2020 and the
first half of 2021, whilst its electrical connector seal business
has seen increased demand as a result of the shift towards
electrification and connectivity in mobility technology
applications and industrial markets. The bolt-on acquisition of
Cardea Catheter Innovations for Cirtec Medical in the period
further diversifies its end-market exposure. The business is well
positioned to continue its long-term strong growth in the coming
years, including in the near term capitalising on expected
re-ramping of inventories of key customers and increasing procedure
volumes following destocking in the last year and general lower
procedures levels that have not fully recovered globally.
As at 30 September 2021, only 1% of the Private Equity portfolio
by value was exposed to the leisure travel end market. arrivia
continues to operate resiliently and saw a noticeable recovery in
bookings in the first six months of 2021 for travel lines such as
hotel, resort, air and car, before momentum slowed over the late
summer as travellers reacted to variants of Covid-19 . Leisure
cruising, arrivia's primary market, remains challenging. Our
expectation is that leisure cruising passenger numbers will recover
through 2022 and 2023. Audley Travel's performance has closely
mirrored Covid-19 incidence rates and Government policy across its
US and UK markets. Recent easing of UK travel restrictions and
improving Covid-19 rates in the US have driven improved enquiries
and bookings across the business. In October 2021, we invested a
further GBP25 million in Audley Travel to support the business as
it recovers from the pandemic. Further information on the valuation
of Audley Travel can be found under the DCF heading below.
Formel D continues to be severely challenged by the continued
contraction of automotive production volumes, delayed production
launches particularly in Europe, which is Formel D's primary
market, by a significant shortage of semiconductors, as well as
company specific operational issues on which progress is being
made.
Overall, 96%(1) of the top 20 portfolio companies by value in
our Private Equity portfolio grew their earnings in the 12 months
to 30 June 2021 (September 2020: 85%) .
1 Includes top 20 Private Equity portfolio companies by value excluding Magnitude Software valued
on imminent sale basis.
Table 6: Portfolio earnings growth of the top 20 Private Equity
investments(1)
3i carrying value
Number of companies at 30 September 2021
at 30 September 2021 GBPm
========= ===================== =====================
<0% 4 463
0 - 9% 4 1,067
10 - 19% 3 1,106
20 - 29% 1 254
>30% 8 7,721
--------- --------------------- ---------------------
1 Includes top 20 Private Equity companies by value excluding Magnitude Software valued on imminent
sale basis. This represents 95%
of the Private Equity portfolio by value (31 March 2021: 98%). LTM adjusted earnings to 30
June 2021 and Action based on LTM run-rate earnings to P9 2021. P9 2021 runs to 3 October
2021.
Leverage across the portfolio was 3.3x at 30 September 2021 (31
March 2021: 3.9x). Excluding Action, leverage across the portfolio
was 4.4x (31 March 2021: 4.3x). Table 7 shows the ratio of net debt
to adjusted earnings by portfolio value at 30 September 2021.
Table 7: Ratio of net debt to adjusted earnings(1)
3i carrying value
Number of companies at 30 September 2021
at 30 September 2021 GBPm
======= ===================== =====================
<1x 4 871
1 - 2x 1 22
2 - 3x 1 6,100
3 - 4x 4 1,148
4 - 5x 5 733
5 - 6x 3 802
>6x 3 144
======= ===================== =====================
1 This represents 88% of the Private Equity portfolio by value (31 March 2021: 88%). Quoted
holdings, assets valued on an imminent sale basis, deferred consideration and companies with
net cash are excluded from the calculation. Net debt and adjusted earnings as at 30 June 2021.
Action based on net debt at P9 2021 and LTM run-rate earnings to P9 2021.
Multiple movements
In setting or changing a multiple, we consider several factors
such as relative performance, investment size, recent comparable
transactions and exit plans, and monitor external equity markets.
Where appropriate, we adjust the multiples for the impact of the
applicable lease accounting standards.
At 30 September 2021, we changed valuation multiples for a small
number of our portfolio companies to reflect their strong
performance and position relative to the sector.
The multiple of run-rate earnings used to value Action at 30
September 2021 remained at 18.5x net of the liquidity discount .
Based on the valuation of the investment at 30 September 2021, a
1.0x movement in Action's post-discount multiple would have an
impact of GBP383 million on the valuation of 3i's investment.
DCF
Audley Travel remains valued on a DCF basis and its valuation
reflects our continuing expectation that a sustained recovery in
the UK and US travel markets to 2019 levels will take some
time.
Imminent sale
At 30 September 2021, Magnitude Software was valued on an
imminent sale basis after we agreed a sale of the business at a
109% uplift to opening value at 31 March 2021. The significant
uplift reflects the current market conditions, investments made in
the business during our ownership, and the strategic value of the
business . We received proceeds of GBP345 million in November 2021
from the divestment.
Quoted portfolio
Basic-Fit is the only quoted asset in the Private Equity
portfolio. We recognised an unrealised value gain of GBP45 million
from Basic-Fit in the period (September 2020: GBP28 million) as its
share price increased to EUR39.58 at 30 September 2021 (31 March
2021: EUR32.85). In April 2021, Basic-Fit raised further capital at
EUR34 per share. We did not participate in that equity raise and,
as a result, our residual stake was reduced from 12.8% to 11.6%. At
30 September 2021, our residual 11.6% shareholding was valued at
GBP261 million (31 March 2021: 12.8% shareholding valued at GBP214
million). In November 2021, we announced the partial sale of our
stake in Basic-Fit at EUR44.25 per share, generating proceeds of
c.GBP146 million. We retain a 5.7% holding in that business .
Private Equity proprietary capital
At 30 September 2021, the portfolio consisted of 34 assets (31
March 2021: 33 assets). The value of 3i's Private Equity
proprietary capital increased to GBP11.1 billion (31 March 2021:
GBP8.8 billion) principally due to unrealised value movements in
the period.
Table 8: Private Equity 3i proprietary capital
Proprietary capital value Vintage Proprietary capital value Vintage
30 September 2021 money multiple (3) 31 March 2021 money multiple (3)
Vintages (1) GBPm 30 September 2021 GBPm 31 March 2021
=================== ========================== =================== ========================== ===================
Buyouts 2010-2012 2,096 11.3x 1,569 10.2x
Growth 2010-2012 18 2.1x 16 2.1x
2013-2016 953 2.2x 829 2.1x
2016-2019 2,505 1.8x 2,062 1.4x
2019-2022 863 1.3x 745 1.1x
Other(2) 4,680 n/a 3,593 n/a
=================== ========================== =================== ========================== ===================
Total 11,115 8,814
=================== ========================== =================== ========================== ===================
1 Assets included in these vintages are disclosed in the Glossary at the end of this document.
2 Includes value of GBP4,004 million (31 March 2021: GBP2,997 million) held in Action through
the 2020 Co-investment vehicles and 3i.
3 Vintage money multiple includes unrealised value.
The value of the Private Equity portfolio including third-party
capital increased to GBP14.8 billion (31 March 2021: GBP11.6
billion) principally due to the increase in the valuations of
Action and several other top 20 Private Equity assets.
Table 9: Private Equity assets by geography
3i carrying value
at 30 September 2021
3i office location Number of companies GBPm
==================== ==================== =====================
Netherlands 5 7,219
France 2 548
Germany 7 922
UK 8 904
US 9 1,500
Other 3 22
==================== ==================== =====================
Total 34 11,115
==================== ==================== =====================
Infrastructure
Our infrastructure business generated a GIR of GBP60 million, or
5% on the opening portfolio value (September 2020: GBP134 million,
12%) in the period, principally from 3iN's share price appreciation
and dividend income.
Table 10: Gross investment return for the six months to 30
September
2021 2020
Investment basis GBPm GBPm
=========================================================== ===== =====
Realised profits 3 -
Unrealised profits on the revaluation of investments 30 127
Dividends 15 14
Interest income from investment portfolio 5 5
Foreign exchange on investments 7 (16)
Movement in the fair value of derivatives - 4
=========================================================== ===== =====
Gross investment return 60 134
=========================================================== ===== =====
Gross investment return as a % of opening portfolio value 5% 12%
=========================================================== ===== =====
3iN performance
The 3iN portfolio is performing strongly, with the majority of
its portfolio companies meeting or exceeding the expectations set
at the beginning of this financial year. In the six months to 30
September 2021, 3iN generated a total return on opening NAV of
10.6% (September 2020: 4%) and is on track to meet its dividend
target of 10.45 pence per share, up 6.6% year-on-year.
In the period, 3iN completed the acquisition of a 60% stake in
DNS:NET, an independent telecommunications provider in Germany, for
EUR182 million, and invested GBP12 million in ESVAGT to fund
further growth in the offshore wind segment, including three new
Service Operation Vessels ("SOV") under long term charter with MHI
Vestas. In April 2021, Joulz, an existing portfolio company,
completed the acquisition of Zonel Energy, a provider of solar
rooftop solutions to businesses across the Netherlands. At the end
of September 2021, 3iN announced the divestment of Oystercatcher's
four European terminals driving a 69% uplift to its 31 March 2021
valuation. Oystercatcher continues to own a 45% stake in Oiltanking
Singapore Limited. Oystercatcher's unrealised money multiple is now
3.0x and unrealised IRR is 13.9% over 3iN's 14-year investment
period.
As 3iN's investment manager, 3i received a management fee of
GBP16 million in the period (September 2020: GBP12 million).
Performance of 3i's proprietary capital Infrastructure
portfolio
Table 11: Unrealised profits on the revaluation of
Infrastructure investments(1) in the six months to 30 September
2021 2020
GBPm GBPm
=============== ===== =====
Quoted 20 113
DCF 8 7
Fund 2 1
Imminent sale - 6
=============== ===== =====
Total 30 127
=============== ===== =====
1 More information on our valuation methodology, including definitions and rationale, is included
in our Annual report and accounts 2021 on pages 188 to 189.
Quoted stake in 3iN
3iN's share price increased by 3% in the first half of the year
and closed at 304 pence on 30 September 2021 (31 March 2021: 296
pence). We recognised GBP20 million of unrealised profits on our
3iN investment and GBP13 million of dividend income (September
2020: GBP113 million of unrealised value growth and GBP12 million
of dividend income). At 30 September 2021, our investment in 3iN
was valued at GBP817 million (31 March 2021: GBP797 million).
US Infrastructure
Regional Rail has seen good performance with the business
benefitting from its geographic and end-market diversification.
Smarte Carte performed well in the period compared to the same
period in 2020, with its airport carts segment being the key driver
of performance, following an accelerated recovery of US domestic
leisure travel. However, caution remains over the timing of the
recovery of the international travel market. Both assets were
valued on a DCF basis at 30 September 2021.
Other funds
The 3i European Operational Projects Fund and 3i Managed
Infrastructure Acquisitions LP performed in line with expectations
in the period. At the end of September 2021, the 3i European
Operational Projects Fund made a c.EUR30 million commitment to
invest in NEoT Green Mobility to fund its pipeline of future
projects of which EUR6.5 million has been drawn to date. The fund
is now c.70% committed. In the period we recognised GBP6 million of
realised proceeds from KMC Roads, an investment in our 3i India
Infrastructure Fund.
Infrastructure AUM increased to GBP5.1 billion (31 March 2021:
GBP4.9 billion) and we generated fee income of GBP23 million from
our fund management activities in the period (September 2020: GBP19
million).
Table 12: Assets under management as at 30 September 2021
Fee
income
% invested (2) at earned in
Close 3i commitment/ Remaining 3i September AUM the period
Fund/strategy date Fund size share commitment 2021 GBPm GBPm
====================== ========= ========== =============== ============= ================== ====== ===========
3iN(1) Mar 07 n/a GBP817m n/a n/a 2,706 16
3i Managed
Infrastructure
Acquisitions LP Jun 17 GBP698m GBP35m GBP5m 86% 979 3
3i European
Operational Projects
Fund Apr 18 EUR456m EUR40m EUR14m 62% 242 1
BIIF May 08 GBP680m n/a n/a 90% 462 2
3i India Mar 08 US$1,195m US$250m USD$35m 73% - -
Infrastructure Fund
3i managed accounts various n/a n/a n/a n/a 353 1
US Infrastructure various n/a n/a n/a n/a 310 -
====================== ========= ========== =============== ============= ================== ====== ===========
Total 5,052 23
================================= ========== =============== ============= ================== ====== ===========
1 AUM based on the share price at 30 September 2021.
2 % invested is the capital deployed into investments against the total Fund commitment.
Scandlines
Scandlines generated a GIR of GBP30 million (September 2020:
GBP15 million) or 7% of opening portfolio value (September 2020:
3%) in the period.
Table 13: Gross investment return for the six months to 30
September
2021 2020
Investment basis GBPm GBPm
=========================================================== ===== =====
Unrealised profit on the revaluation of investments 30 12
Foreign exchange on investments 4 11
Movement in the fair value of derivatives (4) (8)
=========================================================== ===== =====
Gross investment return 30 15
=========================================================== ===== =====
Gross investment return as a % of opening portfolio value 7% 3%
=========================================================== ===== =====
Performance
Scandlines performed well in the period. Freight volumes
remained resilient and were ahead of 2019 levels. As expected,
leisure travel and shopping ticket volumes were weak in the first
six months of 2021 as a result of travel restrictions. However,
following the lifting of restrictions at the start of July 2021,
leisure travel trading has improved, and volumes are now back to
2019 levels. The business remains cash generative and is well
positioned to resume its distributions.
At 30 September 2021, Scandlines was valued at GBP469 million
(31 March 2021: GBP435 million) on a DCF basis.
Foreign exchange
We hedge the balance sheet value of our investment in
Scandlines. We recognised no gain or loss on foreign exchange
translation (September 2020: GBP3 million gain).
Overview of financial performance
3i generated a total return of GBP2,199 million, or a profit on
opening shareholders' funds of 24%, in the six months to 30
September 2021 (September 2020: GBP1,142 million, or 15%). The
diluted NAV per share at 30 September 2021 increased to 1,153 pence
(31 March 2021: 947 pence) after the payment of the second FY2021
dividend of GBP203 million, or 21.0 pence per share (September
2020: GBP169 million, 17.5 pence per share) in July 2021.
Table 14: Gross investment return for the six months to 30
September
2021 2020
Investment basis GBPm GBPm
=========================================================== ====== ======
Private Equity 2,373 1,245
Infrastructure 60 134
Scandlines 30 15
Gross investment return 2,463 1,394
=========================================================== ====== ======
Gross investment return as a % of opening portfolio value 24% 17%
----------------------------------------------------------- ------ ------
Total comprehensive income ("Total return") 2,199 1,142
=========================================================== ====== ======
Total return on opening shareholders' funds 24% 15%
=========================================================== ====== ======
GIR was GBP2,463 million in the period (September 2020: GBP1,394
million) driven by the strong performance of Action and the
majority of our other top 20 investments. The GIR also includes a
GBP104 million net foreign currency gain on translation of our
investments (September 2020: GBP88 million gain). Further
information on the Private Equity, Infrastructure and Scandlines
valuations is included in their respective sections of this
Business and Financial review.
Operating cash (loss)/profit
Table 15: Operating cash (loss)/profit for the six months to 30
September
2021 2020
GBPm GBPm
======================================= ===== =====
Cash fees from external funds 24 19
Cash portfolio fees 3 2
Cash portfolio dividends and interest 26 62
======================================= ===== =====
Cash income 53 83
Cash operating expenses(1) (72) (69)
======================================= ===== =====
Operating cash (loss)/profit (19) 14
======================================= ===== =====
1 Cash operating expenses include operating expenses paid and lease payments.
3i generated an operating cash loss of GBP19 million in the
period (September 2020: GBP14 million profit). Cash income
decreased to GBP53 million (September 2020: GBP83 million)
principally due to the reduction of dividend income compared to the
same period last year, which included a significant non-recurring
dividend. Cash operating expenses incurred during the period
increased to GBP72 million (September 2020: GBP69 million) driven
principally by higher variable compensation costs. We expect to
report an operating cash profit at 31 March 2022, due to a good
pipeline of cash income.
Foreign exchange
At 30 September 2021, 86% of the Group's assets were denominated
in euros or US dollars (31 March 2021: 84%). The Group recorded a
total foreign exchange gain of GBP98 million net of derivatives
during the period (September 2020: GBP80 million) as a result of
the weakening of sterling against the euro and US dollar.
Table 16: Net assets and sensitivity by currency at 30 September
2021
Net 1%
assets sensitivity
FX rate GBPm % GBPm
============== ======== ======= === ============
Sterling n/a 1,269 12 n/a
Euro(1) 1.1633 7,813 70 77
US dollar 1.3481 1,827 16 18
Danish krone 8.6500 240 2 2
Other n/a 24 - n/a
============== ======== ======= === ============
Total 11,173
============== ======== ======= === ============
1 Sensitivity impact is net of derivatives.
Carried interest and performance fees payable and receivable
We pay carried interest to participants in plans relating to our
proprietary capital invested. We also receive performance fees from
third-party funds and pay a portion of that carry received to
participants in our carry plans. Carried interest at 30 September
2021 was calculated assuming that remaining assets in the portfolio
were realised at their fair value at that date.
Table 17: Carried interest and performance fees for the six
months to 30 September
Consolidated statement of comprehensive income 2021 2020
GBPm GBPm
================================================== ====== =====
Carried interest and performance fees receivable
Private Equity 2 (2)
================================================== ====== =====
Total 2 (2)
================================================== ====== =====
Carried interest and performance fees payable
Private Equity (194) (61)
Infrastructure (6) (2)
================================================== ====== =====
Total (200) (63)
================================================== ====== =====
Net carried interest payable (198) (65)
================================================== ====== =====
Table 18: Carried interest and performance fees
Consolidated statement of financial position 30 September 31 March
2021 2021
GBPm GBPm
================================================== ============= =========
Carried interest and performance fees receivable
Private Equity 10 8
Infrastructure - 8
Total 10 16
================================================== ============= =========
Carried interest and performance fees payable
Private Equity (727) (533)
Infrastructure (10) (27)
================================================== ============= =========
Total (737) (560)
================================================== ============= =========
Carried interest and performance fees payable
In Private Equity, we typically accrue net carried interest
payable at between 10% and 13% of gross investment return. We
accrued carried interest payable of GBP194 million (September 2020:
GBP61 million) for Private Equity in the period. This was driven by
the strong gross investment return generated from the 2016-19
vintage and the continued strong performance of the 2010-12
vintage, which includes Action. We are not yet accruing carried
interest payable for the 2019-22 vintage.
Carried interest is paid to participants when cash proceeds have
actually been received following a realisation, refinancing event
or other cash distribution and performance hurdles are passed in
cash terms. Due to the length of time between investment and
realisation, the schemes are long term in nature and active for a
number of years. Their participants are both current and previous
employees of 3i.
Overall, the effect of the income statement charge, the cash
payments, as well as the currency translation meant that the
balance sheet carried interest and performance fees payable
increased to GBP737 million (31 March 2021: GBP560 million).
Balance sheet and NAV
Table 19: Simplified consolidated balance sheet
30 September 31 March
2021 2021
Investment basis GBPm GBPm
================================================== ============= =========
Investment portfolio 12,784 10,408
Gross debt (975) (975)
Cash and deposits 44 225
================================================== ============= =========
Net debt (931) (750)
================================================== ============= =========
Carried interest and performance fees receivable 10 16
Carried interest and performance fees payable (737) (560)
Other net assets 47 50
================================================== ============= =========
Net assets 11,173 9,164
================================================== ============= =========
Gearing(1) 8% 8%
================================================== ============= =========
1 Gearing is net debt as a percentage of net assets.
The investment portfolio value increased to GBP12,784 million at
30 September 2021 (31 March 2021: GBP10,408 million) driven by
unrealised profit of GBP2,279 million and gains on foreign exchange
translation offsetting net divestment.
At 30 September 2021 the Group had net debt of GBP931 million
(31 March 2021: GBP750 million) after the payment of the second
FY2021 dividend of GBP203 million, carried interest of GBP13
million and net divestment of
GBP64 million.
Going concern and liquidity
The Half-year consolidated financial statements are prepared on
a going concern basis following the assessment by the Directors,
taking into account the Group's current performance and
outlook.
Liquidity reduced to GBP544 million at 30 September 2021 (31
March 2021: GBP725 million) and comprised cash and deposits of
GBP44 million (31 March 2021: GBP225 million) and an undrawn
facility of GBP500 million (31 March 2021: GBP500 million).
Alternative Performance Measures ("APMs")
We assess our performance using a variety of measures that are
not specifically defined under IFRS and are therefore termed APMs.
The APMs that we use may not be directly comparable with those used
by other companies. Our Investment basis is itself an APM.
The explanation of and rationale for the Investment basis and
its reconciliation to IFRS is provided in the Reconciliation of the
Investment basis to IFRS section. The table below defines our
additional APMs and should be read in conjunction with our Annual
report and accounts 2021.
APM Purpose Calculation Reconciliation to
IFRS
Gross investment A measure of the performance It is calculated The equivalent balances
return as a percentage of our proprietary as the gross investment under IFRS and the
of opening portfolio investment portfolio. return, as shown reconciliation to
value For further information, in the Investment the Investment basis
see the Group KPIs basis Consolidated are shown in the
in our Annual report statement of comprehensive Reconciliation of
and accounts 2021. income, as a % of consolidated statement
the opening portfolio of comprehensive
value. income and the Reconciliation
of consolidated
statement of financial
position respectively.
================================ =========================== ==============================
Cash realisations Cash proceeds from The cash received The equivalent balance
our investments support from the disposal under IFRS and the
our returns to shareholders, of investments in reconciliation to
as well as our ability the period as shown the Investment basis
to invest in new opportunities. in the Investment is shown in the
For further information, basis Consolidated Reconciliation of
see the Group KPIs cash flow statement. consolidated cash
in our Annual report flow statement.
and accounts 2021.
================================ =========================== ==============================
Cash investment Identifying new opportunities The cash paid to The equivalent balance
in which to invest acquire investments under IFRS and the
proprietary capital in the period as reconciliation to
is the primary driver shown on the Investment the Investment basis
of the Group's ability basis Consolidated is shown in the
to deliver attractive cash flow statement. Reconciliation of
returns. For further consolidated cash
information, see the flow statement.
Group KPIs in our Annual
report and accounts
2021.
================================ =========================== ==============================
Operating cash By covering the cash The cash income The equivalent balance
profit/(loss) cost of running the from the portfolio under IFRS and the
business with cash (interest, dividends reconciliation to
income, we reduce the and fees) together the Investment basis
potential dilution with fees received is shown in the
of capital returns. from external funds Reconciliation of
For further information, less cash operating consolidated cash
see the Group KPIs expenses and leases flow statement.
in our Annual report payments as shown
and accounts 2021. on the Investment
basis Consolidated
cash flow statement.
The calculation
is shown in Table
15 of the Overview
of financial performance.
================================ =========================== ==============================
Net cash/(net A measure of the available Cash and cash equivalents The equivalent balance
debt) cash to invest in the plus deposits less under IFRS and the
business and an indicator loans and borrowings reconciliation to
of the financial risk as shown on the the Investment basis
in the Group's balance Investment basis is shown in the
sheet. Consolidated statement Reconciliation of
of financial position. consolidated statement
of financial position.
================================ =========================== ==============================
Gearing A measure of the financial Net debt (as defined The equivalent balance
risk in the Group's above) as a % of under IFRS and the
balance sheet. the Group's net reconciliation to
assets under the the Investment basis
Investment basis. is shown in the
It cannot be less Reconciliation of
than zero. consolidated statement
of financial position.
================================ =========================== ==============================
Principal risks and uncertainties
3i's risk appetite statement, approach to risk management and
governance structure are set out in the Risk section of the Annual
report and accounts 2021, which can be accessed on the Group's
website at www.3i.com .
The principal risks to the achievement of the Group's strategic
objectives for the remaining six months of its financial year are
largely unchanged from those reported on pages 58 to 62 of the
Annual report and accounts 2021. The impact and likelihood of the
majority of the Group's principal risks were stable in the
period.
Covid-19
The Covid-19 vaccine roll-out has enabled a gradual re-opening
of economies in the period but with evidence of increased price
inflation, material and labour shortages and supply chain
disruption. These economic headwinds have the potential to affect
the pace of recovery and, in turn, trading, liquidity and
valuations in varying degrees across the investment portfolio. As
outlined below, 3i has a well-funded balance sheet and the
investment portfolio has continued to perform well.
Principal risks
External - Risks arising from external factors including
political, legal, regulatory, economic and competitor changes,
which affect the Group's investment portfolio and operations.
As noted above, there is ongoing uncertainty in the outlook for
the global economy which will be influenced by the continuing
effectiveness of Covid-19 vaccine programmes and the extent to
which inflation and supply-side constraints impact the recovery
momentum. 3i is not immune to these wider market conditions;
however, our balance sheet is well funded with low holding company
debt and we have a diverse portfolio of international companies
operating in a range of different sectors.
Investment - Risks in respect of specific asset investment
decisions, the subsequent performance of an investment or exposure
concentrations across business line portfolios.
The portfolio continues to show strong performance in the
current economic conditions. Covid-19 restrictions continue to
affect a very limited number of portfolio assets in the most
exposed sectors e.g. travel, but these are not material to the
overall performance.
Operational - Risks arising from inadequate or failed processes,
people and systems or from external factors affecting these.
The Group's day-to-day operations have been largely unaffected
by the ongoing impact of Covid-19 related restrictions, and the
transition from remote to more hybrid, office-based working
arrangements. This includes the continued resilience and security
of the Group's IT systems; maintaining robust processes and
internal controls; and providing appropriate levels of support for
our staff. Staff turnover rates have remained low notwithstanding
an increasingly competitive recruitment market.
The Half-year report provides an update on 3i's strategy and
business performance, as well as on market conditions, which is
relevant to the Group's overall risk profile and should be viewed
in the context of the Group's risk management framework and
principal risks as disclosed in the Annual report and accounts
2021.
Reconciliation of the Investment basis to IFRS
Background to Investment basis numbers used in the Half-year
report
The Group makes investments in portfolio companies directly,
held by 3i Group plc, and indirectly, held through intermediate
holding company and partnership structures ("investment entity
subsidiaries"). It also has other operational subsidiaries, which
provide services and other activities such as employment,
regulatory activities, management and advice ("trading
subsidiaries"). The application of IFRS 10 requires us to fair
value a number of investment entity subsidiaries that were
previously consolidated line by line. This fair value approach,
applied at the investment entity subsidiary level, effectively
obscures the performance of our proprietary capital investments and
associated transactions occurring in the investment entity
subsidiaries.
The financial effect of the underlying portfolio companies and
fee income, operating expenses and carried interest transactions
occurring in investment entity subsidiaries are aggregated into a
single value. Other items which were previously eliminated on
consolidation are now included separately.
To maintain transparency and aid understanding of our results,
we include a separate non-GAAP "Investment basis" consolidated
statement of comprehensive income, financial position and cash
flow. The Investment basis is an APM and the Chief Executive's
review and the Business and financial review are prepared using the
Investment basis, as we believe it provides a more understandable
view of our performance. Total return and net assets are equal
under the Investment basis and IFRS; the Investment basis is simply
a "look through" of IFRS 10 to present the underlying
performance.
A more detailed explanation of the effect of IFRS 10 is provided
in the Annual report and accounts 2021 on page 45.
Reconciliation between Investment basis and IFRS
A detailed reconciliation from the Investment basis to IFRS
basis of the Consolidated statement of comprehensive income,
Consolidated statement of financial position and Consolidated cash
flow statement is shown below.
Reconciliation of consolidated statement of comprehensive
income
Six months to 30 September 2021 Six months to 30 September 2020
Investment IFRS IFRS Investment IFRS IFRS
basis adjustments Basis basis adjustments basis
(unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)
Notes GBPm GBPm GBPm GBPm GBPm GBPm
================== ===== =========== =========== =========== ================ =========== ===============
Realised profits
over value
on the disposal
of investments 1,2 15 (4) 11 3 2 5
Unrealised profits
on the
revaluation of
investments 1,2 2,279 (1,205) 1,074 1,210 (605) 605
Fair value
movements
on investment
entity
subsidiaries 1 - 1,094 1,094 - 634 634
Portfolio income
Dividends 1,2 25 (3) 22 57 (27) 30
Interest income
from investment
portfolio 1,2 38 (25) 13 30 (20) 10
Fees receivable 1,2 2 1 3 6 1 7
Foreign exchange
on investments 1,4 108 (66) 42 92 (78) 14
Movement in the
fair value of
derivatives (4) - (4) (4) - (4)
================== ===== =========== =========== =========== ================ =========== ===============
Gross investment
return 2,463 (208) 2,255 1,394 (93) 1,301
================== ===== =========== =========== =========== ================ =========== ===============
Fees receivable
from external
funds 25 - 25 21 - 21
Operating expenses 1,3 (56) - (56) (58) 1 (57)
Interest received 1 - - - (1) 1 -
Interest paid (27) - (27) (23) - (23)
Exchange movements 1,4 (6) 5 (1) (8) 5 (3)
Income from
investment entity
subsidiaries 1 - 11 11 - 12 12
Operating profit
before carried
interest 2,399 (192) 2,207 1,325 (74) 1,251
================== ===== =========== =========== =========== ================ =========== ===============
Carried interest
Carried interest
and performance
fees receivable 1,3 2 - 2 (2) - (2)
Carried interest
and performance 68
fees payable 1,3 (200) 190 (10) (63) 5
================= ===== =========== =========== =========== ================ =========== ===============
Operating profit
before tax 2,201 (2) 2,199 1,260 (6) 1,254
================== ===== =========== =========== =========== ================ =========== ===============
Tax charge 1,3 (2) - (2) - - -
================== ===== =========== =========== =========== ================ =========== ===============
Profit for the
period 2,199 (2) 2,197 1,260 (6) 1,254
================== ===== =========== =========== =========== ================ =========== ===============
Other comprehensive
income that may
be reclassified to the
income statement
Exchange
differences on
translation of
foreign
operations 1,4 - 2 2 - 6 6
Other comprehensive
expense that will not
be reclassified to the
income statement
Re-measurement of
defined
benefit plans - - - (118) - (118)
================= ===== =========== =========== =========== ================ =========== ===============
Other
comprehensive
income/(expense)
for the period - 2 2 (118) 6 (112)
================== ===== =========== =========== =========== ================ =========== ===============
Total
comprehensive
income for
the period
("Total return") 2,199 - 2,199 1,142 - 1,142
================== ===== =========== =========== =========== ================ =========== ===============
Notes:
1 Applying IFRS 10 to the Consolidated statement of comprehensive income consolidates the line
items of a number of previously consolidated subsidiaries into a single line item "Fair value
movements on investment entity subsidiaries". In the Investment basis accounts we have disaggregated
these line items to analyse our total return as if these investment entity subsidiaries were
fully consolidated, consistent with prior periods. The adjustments simply reclassify the Consolidated
statement of comprehensive income of the Group, and the total return is equal under the Investment
basis and the IFRS basis.
2 Realised profits, unrealised profits and portfolio income shown in the IFRS accounts only
relate to portfolio companies that are held directly by 3i Group plc and not those portfolio
companies held through investment entity subsidiaries. Realised profits, unrealised profits
and portfolio income in relation to portfolio companies held through investment entity subsidiaries
are aggregated into the single "Fair value movement on investment entity subsidiaries" line.
This is the most significant reduction of information in our IFRS accounts.
3 Other items also aggregated into the "Fair value movements on investment entity subsidiaries"
line include operating expenses, carried interest and performance fees receivable, carried
interest and performance fees payable and tax. Operating expenses, carried interest and performance
fees receivable and tax do not impact fair value movements on investment entity subsidiaries
for the six months to 30 September 2021.
4 Foreign exchange movements have been reclassified under the Investment basis as foreign currency
asset and liability movements. Movements within the investment entity subsidiaries are included
within "Fair value movements on investment entity subsidiaries".
Reconciliation of consolidated statement of financial
position
As at 30 September 2021 As at 31 March 2021
Investment IFRS IFRS Investment IFRS IFRS
basis adjustments basis basis adjustments basis
(unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (audited)
Notes GBPm GBPm GBPm GBPm GBPm GBPm
==== ============================== ============ ============ ============ ============ ============ ==========
Assets
Non-current assets
Investments
Quoted investments 1 1,078 (261) 817 1,011 (214) 797
Unquoted investments 1 11,706 (6,407) 5,299 9,397 (5,184) 4,213
Investments in investment
entity subsidiaries 1,2 - 5,983 5,983 - 4,905 4,905
============================== ==== ============ ============ ============ ============ ============ ==========
Investment portfolio 12,784 (685) 12,099 10,408 (493) 9,915
============================== ==== ============ ============ ============ ============ ============ ==========
Carried interest and
performance
fees receivable 1 10 1 11 8 1 9
Other non-current assets 1 60 (4) 56 54 (2) 52
Intangible assets 7 - 7 8 - 8
Retirement benefit surplus 55 - 55 55 - 55
Property, plant and equipment 4 - 4 5 - 5
Right of use asset 15 - 15 16 - 16
Derivative financial
instruments 9 - 9 16 - 16
Deferred income taxes 1 - 1 1 - 1
Total non-current assets 12,945 (688) 12,257 10,571 (494) 10,077
============================== ==== ============ ============ ============ ============ ============ ==========
Current assets
Carried interest and
performance
fees receivable 1 - - - 8 - 8
Other current assets 1 20 (2) 18 21 - 21
Current income taxes 2 - 2 2 - 2
Derivative financial
instruments 9 - 9 10 - 10
Cash and cash equivalents 1 44 (7) 37 225 (9) 216
============================== ==== ============ ============ ============ ============ ============ ==========
Total current assets 75 (9) 66 266 (9) 257
============================== ==== ============ ============ ============ ============ ============ ==========
Total assets 13,020 (697) 12,323 10,837 (503) 10,334
============================== ==== ============ ============ ============ ============ ============ ==========
Liabilities
Non-current liabilities
Trade and other payables 1 (24) 7 (17) (24) 7 (17)
Carried interest and
performance
fees payable 1 (732) 689 (43) (543) 494 (49)
Loans and borrowings (975) - (975) (975) - (975)
Retirement benefit deficit (29) - (29) (29) - (29)
Lease liability (11) - (11) (13) - (13)
Derivative financial
instruments (1) - (1) - - -
Deferred income taxes (1) - (1) (1) - (1)
Provisions (2) - (2) (2) - (2)
============================== ==== ============ ============ ============ ============ ============ ==========
Total non-current liabilities (1,775) 696 (1,079) (1,587) 501 (1,086)
============================== ==== ============ ============ ============ ============ ============ ==========
Current liabilities
Trade and other payables 1 (61) 1 (60) (64) 2 (62)
Carried interest and
performance fees payable 1 (5) - (5) (17) - (17)
Lease liability (5) - (5) (4) - (4)
Current income taxes (1) - (1) (1) - (1)
Total current liabilities (72) 1 (71) (86) 2 (84)
============================== ==== ============ ============ ============ ============ ============ ==========
Total liabilities (1,847) 697 (1,150) (1,673) 503 (1,170)
============================== ==== ============ ============ ============ ============ ============ ==========
Net assets 11,173 - 11,173 9,164 - 9,164
============================== ==== ============ ============ ============ ============ ============ ==========
Equity
Issued capital 719 - 719 719 - 719
Share premium 789 - 789 788 - 788
Other reserves 3 9,711 - 9,711 7,721 - 7,721
Own shares (46) - (46) (64) - (64)
============================== ==== ============ ============ ============ ============ ============ ==========
Total equity 11,173 - 11,173 9,164 - 9,164
============================== ==== ============ ============ ============ ============ ============ ==========
Notes:
1 Applying IFRS 10 to the Consolidated statement of financial position
aggregates the line items of investment entity subsidiaries into the
single line item "Investments in investment entity subsidiaries".
In the Investment basis, we have disaggregated these items to analyse
our net assets as if the investment entity subsidiaries were consolidated.
The adjustment reclassifies items in the Consolidated statement of
financial position. There is no change to the net assets, although
for reasons explained below, gross assets and gross liabilities are
different. The disclosure relating to portfolio companies is significantly
reduced by the aggregation, as the fair value of all investments held
by investment entity subsidiaries is aggregated into the "Investments
in investment entity subsidiaries" line. We have disaggregated this
fair value and disclosed the underlying portfolio holding in the relevant
line item, ie quoted investments or unquoted investments. Other items
which may be aggregated include carried interest, other assets and
other payables, and the Investment basis presentation again disaggregates
these items.
2 Intercompany balances between investment entity subsidiaries and trading
subsidiaries also impact the transparency of our results under the
IFRS basis. If an investment entity subsidiary has an intercompany
balance with a consolidated trading subsidiary of the Group, then
the asset or liability of the investment entity subsidiary will be
aggregated into its fair value, while the asset or liability of the
consolidated trading subsidiary will be disclosed as an asset or liability
in the Consolidated statement of financial position of the Group.
3 Investment basis financial statements are prepared for performance
measurement and therefore reserves are not analysed separately under
this basis.
Reconciliation of consolidated cash flow statement
Six months to 30 September 2021 Six months to 30 September 2020
Investment IFRS IFRS Investment IFRS IFRS
basis adjustments basis basis adjustments basis
(unaudited) (unaudited) (unaudited) (unaudited) (unaudited) (unaudited)
Notes GBPm GBPm GBPm GBPm GBPm GBPm
========================== ====== ============ ============ ============ ============ ============ ============
Cash flow from operating
activities
Purchase of investments 1 (59) 35 (24) (202) 141 (61)
Proceeds from investments 1 123 (61) 62 187 (79) 108
Amounts paid to
investment entity
subsidiaries 1 - (50) (50) - (647) (647)
Amounts received from
investment entity
subsidiaries 1 - 78 78 - 192 192
Net cash flow from
derivatives 6 - 6 3 - 3
Portfolio interest
received 1 - - - 5 (5) -
Portfolio dividends
received 1 26 (3) 23 57 (27) 30
Portfolio fees received 1 3 - 3 2 - 2
Fees received from
external funds 24 - 24 19 - 19
Carried interest and
performance fees
received 1 8 - 8 6 - 6
Carried interest and
performance fees paid 1 (13) - (13) (400) 374 (26)
Operating expenses paid (70) - (70) (67) - (67)
Co-investment loans
(paid)/received 1 (4) - (4) 13 - 13
Tax paid (1) - (1) - - -
Interest received 1 - - - (1) 1 -
Net cash flow from
operating activities 43 (1) 42 (378) (50) (428)
========================== ====== ============ ============ ============ ============ ============ ============
Cash flow from financing
activities
Dividend paid (203) - (203) (169) - (169)
Proceeds from long-term
borrowing - - - 395 - 395
Lease payments (2) - (2) (2) - (2)
Interest paid (19) - (19) (12) - (12)
Net cash flow from
financing activities (224) - (224) 212 - 212
========================== ====== ============ ============ ============ ============ ============ ============
Change in cash and cash
equivalents 2 (181) (1) (182) (166) (50) (216)
========================== ====== ============ ============ ============ ============ ============ ============
Cash and cash equivalents
at the start of the
period 2 225 (9) 216 845 (74) 771
Effect of exchange rate
fluctuations 1 - 3 3 8 (2) 6
Cash and cash equivalents
at the end of the period 2 44 (7) 37 687 (126) 561
========================== ====== ============ ============ ============ ============ ============ ============
Notes:
1 The Consolidated cash flow statement is impacted by the application
of IFRS 10 as cash flows to and from investment entity subsidiaries
are disclosed, rather than the cash flows to and from the underlying
portfolio. Therefore, in our Investment basis financial statements,
we have disclosed our consolidated cash flow statement on a "look through"
basis, in order to reflect the underlying sources and uses of cash
flows and disclose the underlying investment activity.
2 There is a difference between the change in cash and cash equivalents
of the Investment basis financial statements and the IFRS financial
statements because there are cash balances held in investment entity
subsidiaries. Cash held within investment entity subsidiaries will
not be shown in the IFRS statements but will be seen in the Investment
basis statements.
IFRS Financial statements
Condensed consolidated statement of comprehensive income
Six months to Six months to
30 September 30 September
2021 2020
(unaudited) (unaudited)
Notes GBPm GBPm
=========================================================================== ======= ============== ==============
Realised profits over value on the disposal of investments 2 11 5
Unrealised profits on the revaluation of investments 3 1,074 605
Fair value movements on investment entity subsidiaries 8 1,094 634
Portfolio income
Dividends 22 30
Interest income from investment portfolio 13 10
Fees receivable 4 3 7
Foreign exchange on investments 42 14
Movement in the fair value of derivatives (4) (4)
=========================================================================== ======= ============== ==============
Gross investment return 2,255 1,301
--------------------------------------------------------------------------- ------- -------------- --------------
Fees receivable from external funds 4 25 21
Operating expenses (56) (57)
Interest paid (27) (23)
Exchange movements (1) (3)
Income from investment entity subsidiaries 11 12
Operating profit before carried interest 2,207 1,251
--------------------------------------------------------------------------- ------- -------------- --------------
Carried interest
Carried interest and performance fees receivable 4 2 (2)
Carried interest and performance fees payable (10) 5
========================================================================== ======= ============== ==============
Operating profit before tax 2,199 1,254
--------------------------------------------------------------------------- ------- -------------- --------------
Tax charge (2) -
=========================================================================== ======= ============== ==============
Profit for the period 2,197 1,254
=========================================================================== ======= ============== ==============
Other comprehensive income that may be reclassified to the income statement
Exchange differences on translation of foreign operations 2 6
Other comprehensive expense that will not be reclassified to the income statement
Re-measurements of defined benefit plans - (118)
========================================================================== ======= ============== ==============
Other comprehensive income/(expense) for the period 2 (112)
=========================================================================== ======= ============== ==============
Total comprehensive income for the period ("Total return") 2,199 1,142
=========================================================================== ======= ============== ==============
Earnings per share
Basic (pence) 5 227.4 130.1
Diluted (pence) 5 226.9 130.0
========================================================================== ======= ============== ==============
The Notes to the accounts section forms an integral part of
these financial statements.
Condensed consolidated statement of financial position
30 September 31 March
2021 2021
(unaudited) (audited)
Notes GBPm GBPm
======================================================= ============= ==========
Assets
Non-current assets
Investments
Quoted investments 7 817 797
Unquoted investments 7 5,299 4,213
Investments in investment entity subsidiaries 8 5,983 4,905
=================================================== ============= ==========
Investment portfolio 12,099 9,915
=================================================== ============= ==========
Carried interest and performance fees receivable 11 9
Other non-current assets 56 52
Intangible assets 7 8
Retirement benefit surplus 55 55
Property, plant and equipment 4 5
Right of use asset 15 16
Derivative financial instruments 9 16
Deferred income taxes 1 1
Total non-current assets 12,257 10,077
======================================================= ============= ==========
Current assets
Carried interest and performance fees receivable - 8
Other current assets 18 21
Current income taxes 2 2
Derivative financial instruments 9 10
Cash and cash equivalents 37 216
======================================================= ============= ==========
Total current assets 66 257
======================================================= ============= ==========
Total assets 12,323 10,334
======================================================= ============= ==========
Liabilities
Non-current liabilities
Trade and other payables (17) (17)
Carried interest and performance fees payable (43) (49)
Loans and borrowings (975) (975)
Retirement benefit deficit (29) (29)
Lease liability (11) (13)
Derivative financial instruments (1) -
Deferred income taxes (1) (1)
Provisions (2) (2)
=================================================== ============= ==========
Total non-current liabilities (1,079) (1,086)
======================================================= ============= ==========
Current liabilities
Trade and other payables (60) (62)
Carried interest and performance fees payable (5) (17)
Lease liability (5) (4)
Current income taxes (1) (1)
Total current liabilities (71) (84)
======================================================= ============= ==========
Total liabilities (1,150) (1,170)
======================================================= ============= ==========
Net assets 11,173 9,164
======================================================= ============= ==========
Equity
Issued capital 719 719
Share premium 789 788
Capital redemption reserve 43 43
Share-based payment reserve 27 34
Translation reserve (3) (5)
Capital reserve 8,641 6,733
Revenue reserve 1,003 916
Own shares (46) (64)
=================================================== ============= ==========
Total equity 11,173 9,164
------------------------------------------------------- ------------- ----------
The Notes to the accounts section forms an integral part of
these financial statements.
Condensed consolidated statement of changes in equity
Share-
=====================
Capital based
Share Share redemption payment Translation Capital Revenue Own Total
capital premium reserve reserve reserve reserve(1) reserve(1) shares equity
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
For the six months
to
30 September 2021
(unaudited)
===================== ======== ======== =========== ======== ============ =========== =========== ======= ========
Total equity at the
start of
the period 719 788 43 34 (5) 6,733 916 (64) 9,164
Profit for the
period - - - - - 2,129 68 - 2,197
Exchange differences
on translation of
foreign operations - - - - 2 - - - 2
Re-measurements of
defined benefit - - - - - - - - -
plans
Total comprehensive
income for the
period - - - - 2 2,129 68 - 2,199
===================== ======== ======== =========== ======== ============ =========== =========== ======= ========
Share-based payments - - 12 - - - - 12
Release on
exercise/forfeiture
of share awards - - - (19) - - 19 - -
Exercise of share
awards - - - - - (18) - 18 -
Ordinary dividends - - - - - (203) - - (203)
Issue of ordinary
shares - 1 - - - - - - 1
Total equity at the
end of
the period 719 789 43 27 (3) 8,641 1,003 (46) 11,173
===================== ======== ======== =========== ======== ============ =========== =========== ======= ========
1 Refer to the Glossary at the end of this document for the nature of
the capital and revenue reserves.
Share-
=====================
Capital based
Share Share redemption payment Translation Capital Revenue Own Total
capital premium reserve reserve reserve reserve(1) reserve(1) shares equity
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
For the six months
to
30 September 2020
(unaudited)
===================== ======== ======== =========== ======== ============ =========== =========== ======= =======
Total equity at the
start of
the period 719 788 43 33 (2) 5,432 822 (78) 7,757
Profit for the
period - - - - - 1,164 90 - 1,254
Exchange differences
on translation of
foreign operations - - - - 6 - - - 6
Re-measurements of
defined benefit
plans - - - - - (118) - - (118)
Total comprehensive
income for the
period - - - - 6 1,046 90 - 1,142
===================== ======== ======== =========== ======== ============ =========== =========== ======= =======
Share-based payments - - - 11 - - - - 11
Release on
exercise/forfeiture
of share awards - - - (17) - - 17 - -
Exercise of share
awards - - - - - (11) - 11 -
Ordinary dividends - - - - - (169) - - (169)
Issue of ordinary - - - - - - - - -
shares
Total equity at the
end of
the period 719 788 43 27 4 6,298 929 (67) 8,741
===================== ======== ======== =========== ======== ============ =========== =========== ======= =======
1 Refer to the Glossary at the end of this document for the nature of
the capital and revenue reserves.
The Notes to the accounts section forms an integral part of
these financial statements.
Condensed consolidated cash flow statement
Six months to Six months to
30 September 30 September
2021 2020
(unaudited) (unaudited)
Notes GBPm GBPm
====================================================== ============== ==============
Cash flow from operating activities
Purchase of investments (24) (61)
Proceeds from investments 62 108
Amounts paid to investment entity subsidiaries (50) (647)
Amounts received from investment entity subsidiaries 78 192
Net cash flow from derivatives 6 3
Portfolio dividends received 23 30
Portfolio fees received 3 2
Fees received from external funds 24 19
Carried interest and performance fees received 8 6
Carried interest and performance fees paid (13) (26)
Operating expenses paid (70) (67)
Co-investment loans (paid)/received (4) 13
Tax paid (1) -
Net cash flow from operating activities 42 (428)
====================================================== ============== ==============
Cash flow from financing activities
Dividend paid 6 (203) (169)
Proceeds from long-term borrowing - 395
Lease payments (2) (2)
Interest paid (19) (12)
Net cash flow from financing activities (224) 212
====================================================== ============== ==============
Change in cash and cash equivalents (182) (216)
====================================================== ============== ==============
Cash and cash equivalents at the start of the period 216 771
Effect of exchange rate fluctuations 3 6
Cash and cash equivalents at the end of the period 37 561
====================================================== ============== ==============
The Notes to the accounts section forms an integral part of
these financial statements.
Notes to the condensed consolidated financial statements
Basis of preparation and accounting policies
Compliance with International Financial Reporting Standards
("IFRS")
The Half-year condensed consolidated financial statements of 3i
Group plc have been prepared in accordance with the Disclosure
Guidance and Transparency Rules of the Financial Conduct Authority
and IAS 34 Interim Financial Reporting as adopted for use in the
UK. The Half-year condensed consolidated financial statements
should be read in conjunction with the Annual report and accounts
2021 which have been prepared and approved by the Directors in
accordance with international accounting standards in conformity
with the requirements of the Companies Act 2006 and in accordance
with international financial reporting standards adopted pursuant
to Regulation (EC) No 1606/2002 as it applies in the European
Union. The Annual report and accounts for the year ended 31 March
2022 will be prepared in accordance with UK adopted international
accounting standards.
The Half-year condensed consolidated financial statements are
presented to the nearest million sterling (GBPm), the functional
currency of the Company. The accounting policies applied by 3i
Group plc for the Half-year condensed consolidated financial
statements are consistent with those described on pages 133 to 170
of the Annual report and accounts 2021. There was no change in the
current period to the critical accounting estimates and judgements
applied in 2021, which are stated on page 135 of the Annual report
and accounts 2021.
The financial information for the year ended 31 March 2021 and
for the six months ended 30 September 2021 contained within this
Half-year report does not constitute statutory accounts as defined
in section 434 of the Companies Act 2006. The statutory accounts
for the year to 31 March 2021, prepared under IFRS in conformity
with the requirements of the Companies Act 2006, have been reported
on by KPMG LLP and delivered to the Registrar of Companies. The
report of the Auditor on these statutory accounts was unqualified
and did not contain a statement under section 498(2) or section
498(3) of the Companies Act 2006.
Going concern
These condensed consolidated financial statements are prepared
on a going concern basis. The Directors have made an assessment of
going concern for a period of at least 12 months from the date of
approval of the accounts , taking into account the Group's current
performance, financial position and outlook. The Group has
continued to perform strongly in the period, against a backdrop of
more stabilised financial markets following the global Covid-19
vaccine deployment. To support the going concern assessment the
Directors considered:
-- an analysis of the Group's liquidity, solvency and regulatory
capital position. The Group manages and monitors liquidity
regularly, ensuring it is adequate and sufficient and is
underpinned by its monitoring of investments, realisations,
operating expenses and receipt of portfolio cash income. At 30
September 2021 the Group has liquidity of GBP544 million (31 March
2021: GBP725 million). Liquidity comprised of cash and deposits of
GBP44 million (31 March 2021: GBP225 million) and an undrawn
facility of GBP500 million (31 March 2021: GBP500 million); and
-- the stress test scenarios on the Group's portfolio. The
Directors have modelled a number of severe stress test scenarios
based on the position of the Group as at 30 September 2021. The
scenarios consider the potential impact of continued Covid-19
restrictions and the anticipated recovery profile for each
portfolio company, as well as the impact of a significant downturn
event specifically on the Group's largest asset, Action. These
scenarios include a range of estimated impacts, primarily based on
providing additional support to portfolio companies as a result of
the downturn and delaying the Group's ability to realise and make
new investments. The scenarios are most sensitive to a delay in
realisations which contribute to liquidity of the Group. A key
judgement applied is the extent of a continued Covid-19 related
impact on trading activity and restrictions alongside the likely
recovery profile of portfolio companies. The severe scenarios
include assumptions modelling a "U-shaped" recovery (which
considers an extended and drawn-out recovery in which the economy
is impacted by rolling lockdowns and much reduced economic
activity), and a scenario in which this "U-shaped" recovery is
combined with a material and significant deterioration in the
trading performance of the Group's largest asset, Action .
The results of each of the stress test scenarios indicate that
the Group is able to meet its obligations as they fall due for a
period of at least 12 months from the date of approval of these
financial statements by, in certain cases, making use of
controllable management actions. In all these scenarios the
Directors expect the Group to be able to recover without a
permanent long-term impact on its solvency or capital requirements.
Mitigating actions within management control include reduced new
investment levels and drawing on the existing RCF.
Having performed the assessment on going concern, the Directors
considered it appropriate to prepare the condensed consolidated
financial statements of the Group on a going concern basis, and
have concluded that the Group has sufficient financial resources,
is well placed to manage business risks in the current economic
environment, and can continue operations for a period of at least
12 months from the date of issue of these financial statements.
1 Segmental analysis
The tables below are presented on the Investment basis which is
the basis used by the chief operating decision maker, the Chief
Executive, to monitor the performance of the Group. A description
of the Investment basis and a reconciliation of the Investment
basis to the IFRS financial statements is provided in the
Reconciliation of the Investment basis to IFRS section earlier in
this document. Further detail on the Group's segmental analysis can
be found on pages 137 to 139 of the Annual report and accounts
2021. The remaining Notes are prepared on an IFRS basis.
Investment basis
Private Of which is
Equity Action Infrastructure Scandlines Total(3)
Six months to 30 September 2021 GBPm GBPm GBPm GBPm GBPm
=================================================== ======== ============ =============== =========== =========
Realised profits over value on the disposal
of investments 12 - 3 - 15
Unrealised profits on the revaluation
of investments 2,219 1,491 30 30 2,279
Portfolio income
Dividends 10 - 15 - 25
Interest income from investment portfolio 33 - 5 - 38
Fees receivable 2 - - - 2
Foreign exchange on investments 97 43 7 4 108
Movement in the fair value of derivatives - - - (4) (4)
=================================================== ======== ============ =============== =========== =========
Gross investment return 2,373 1,534 60 30 2,463
=================================================== ======== ============ =============== =========== =========
Fees receivable from external funds 2 - 23 - 25
Operating expenses (35) - (20) (1) (56)
Interest received -
Interest paid (27)
Exchange movements (6)
Operating profit before carried interest 2,399
=================================================== ======== ============ =============== =========== =========
Carried interest
Carried interest and performance fees receivable 2 - - - 2
Carried interest and performance fees payable (194) - (6) - (200)
================================================== ======== ============ =============== =========== =========
Operating profit before tax 2,201
=================================================== ======== ============ =============== =========== =========
Tax charge (2)
=================================================== ======== ============ =============== =========== =========
Profit for the period 2,199
--------------------------------------------------- -------- ------------ --------------- ----------- ---------
Other comprehensive income
Re-measurements of defined benefit plans -
================================================== ======== ============ =============== =========== =========
Total return 2,199
=================================================== ======== ============ =============== =========== =========
Realisations(1) 118 - 6 - 124
Cash investment (58) - (1) - (59)
=================================================== ======== ============ =============== =========== =========
Net divestment 60 - 5 - 65
=================================================== ======== ============ =============== =========== =========
Balance sheet
Opening portfolio value at 1 April 2021 8,814 4,566 1,159 435 10,408
Investment(2) 97 - 1 - 98
Value disposed (106) - (3) - (109)
Unrealised value movement 2,219 1,491 30 30 2,279
Other movement (including foreign exchange) 91 43 13 4 108
=================================================== ======== ============ =============== =========== =========
Closing portfolio value at 30 September 2021 11,115 6,100 1,200 469 12,784
=================================================== ======== ============ =============== =========== =========
1 Realised proceeds may differ from cash proceeds due to timing of receipts.
During the period Private Equity received GBP3 million of cash proceeds
which were recognised as realised proceeds in FY2021. During the period
Infrastructure recognised GBP4 million of realised proceeds which
are to be received in the second half of FY2022.
2 Includes capitalised interest and other non-cash investment.
3 The total is the sum of Private Equity, Infrastructure and Scandlines.
"Of which is Action" is part of Private Equity.
Investment basis
Private Of which is
Equity Action Infrastructure Scandlines Total(4)
Six months to 30 September 2020 GBPm GBPm GBPm GBPm GBPm
=================================================== ======== ============ =============== =========== =========
Realised profits over value on the disposal
of investments 3 - - - 3
Unrealised profits on the revaluation
of investments 1,071 644 127 12 1,210
Portfolio income
Dividends 43 - 14 - 57
Interest income from investment portfolio 25 - 5 - 30
Fees receivable 6 - - - 6
Foreign exchange on investments 97 89 (16) 11 92
Movement in the fair value of derivatives - - 4 (8) (4)
=================================================== ======== ============ =============== =========== =========
Gross investment return 1,245 733 134 15 1,394
=================================================== ======== ============ =============== =========== =========
Fees receivable from external funds 2 19 - 21
Operating expenses (36) (20) (2) (58)
Interest received (1)
Interest paid (23)
Exchange movements (8)
Operating profit before carried interest 1,325
=================================================== ======== ============ =============== =========== =========
Carried interest
Carried interest and performance fees receivable (2) - - (2)
Carried interest and performance fees payable (61) (2) - (63)
================================================== ======== ============ =============== =========== =========
Operating profit before tax 1,260
=================================================== ======== ============ =============== =========== =========
Tax charge -
Profit for the period 1,260
--------------------------------------------------- -------- ------------ --------------- ----------- ---------
Other comprehensive income
Re-measurements of defined benefit plans (118)
================================================== ======== ============ =============== =========== =========
Total return 1,142
=================================================== ======== ============ =============== =========== =========
Realisations(1) 82 - - - 82
Cash investment(2) (231) - (2) - (233)
=================================================== ======== ============ =============== =========== =========
Net investment (149) - (2) - (151)
=================================================== ======== ============ =============== =========== =========
Balance sheet
Opening portfolio value at 1 April 2020 6,552 3,536 1,117 429 8,098
Investment(3) 300 - 2 - 302
Value disposed (80) - - - (80)
Unrealised value movement 1,071 644 127 12 1,210
Other movement (including foreign exchange) 47 89 (10) 11 48
=================================================== ======== ============ =============== =========== =========
Closing portfolio value at 30 September 2020 7,890 4,269 1,236 452 9,578
=================================================== ======== ============ =============== =========== =========
1 Realised proceeds may differ from cash proceeds due to timing of receipts.
During the period Private Equity received GBP105 million of cash proceeds
which were recognised as realised proceeds in FY2020.
2 Investment per the segmental analysis is different to cash investment
per the cashflow due to GBP31 million of syndication in Private Equity
which was recognised in FY2020 and received in FY2021.
3 Includes capitalised interest and other non-cash investment.
4 The total is the sum of Private Equity, Infrastructure and Scandlines.
"Of which is Action" is part of Private Equity.
2 Realised profits over value on the disposal of investments
Six months to 30 September 2021 Unquoted
investments Total
GBPm GBPm
====================================== ============ ======
Realisations 58 58
Valuation of disposed investments (47) (47)
====================================== ============ ======
11 11
====================================== ============ ======
Of which:
- profit recognised on realisations 11 11
- losses recognised on realisations - -
===================================== ============ ======
11 11
===================================== ============ ======
Six months to 30 September 2020 Unquoted
investments Total
GBPm GBPm
====================================== ============ ======
Realisations 5 5
Valuation of disposed investments - -
====================================== ============ ======
5 5
====================================== ============ ======
Of which:
- profit recognised on realisations 5 5
- losses recognised on realisations - -
===================================== ============ ======
5 5
===================================== ============ ======
3 Unrealised profits on the revaluation of investments
Six months to 30 September 2021 Unquoted Quoted
investments investments Total
GBPm GBPm GBPm
============================================ ============ ============ ======
Movement in the fair value of investments 1,054 20 1,074
============================================ ============ ============ ======
Of which:
- unrealised gains 1,065 20 1,085
- unrealised losses (11) - (11)
=========================================== ============ ============ ======
1,054 20 1,074
=========================================== ============ ============ ======
Six months to 30 September 2020 Unquoted Quoted
investments investments Total
GBPm GBPm GBPm
============================================ ============ ============ ======
Movement in the fair value of investments 534 71 605
============================================ ============ ============ ======
Of which:
- unrealised gains 549 71 620
- unrealised losses (15) - (15)
=========================================== ============ ============ ======
534 71 605
=========================================== ============ ============ ======
4 Revenue
Items from the Consolidated statement of comprehensive income
which fall within the scope of IFRS 15 are included in the table
below:
Private
Equity Infrastructure Total
Six months to 30 September 2021 GBPm GBPm GBPm
===================================================== ======== =============== ======
Total revenue by geography (1)
UK 2 21 23
Northern Europe 2 1 3
North America 3 1 4
Other - - -
Total 7 23 30
===================================================== ======== =============== ======
Revenue by type
Fees receivable(2) from portfolio 3 - 3
Fees receivable from external funds 2 23 25
Carried interest and performance fees receivable(2) 2 - 2
Total 7 23 30
===================================================== ======== =============== ======
Private
Equity Infrastructure Total
Six months to 30 September 2020 GBPm GBPm GBPm
===================================================== ======== =============== ======
Total revenue by geography(1)
UK (1) 17 16
Northern Europe 3 2 5
North America 2 - 2
Other 3 - 3
Total 7 19 26
===================================================== ======== =============== ======
Revenue by type
Fees receivable(2) from portfolio 7 - 7
Fees receivable from external funds 2 19 21
Carried interest and performance fees receivable(2) (2) - (2)
Total 7 19 26
===================================================== ======== =============== ======
1 For fees receivable from external funds and carried interest and performance fees receivable
the geography is based on the domicile of the fund.
2 Fees receivable and carried interest receivable above are different to the Investment basis
figures included in Note 1. This is due to the fact that Note 1 is disclosed on the Investment
basis and the table above is shown on the IFRS basis. For an explanation of the Investment
basis and a reconciliation between Investment basis and IFRS basis see the Reconciliation
of the Investment basis to IFRS section earlier in this document.
5 Per share information
The calculation of basic net assets per share is based on the
net assets and the number of shares in issue at the period end.
When calculating the diluted net assets per share, the number of
shares in issue is adjusted for the effect of all dilutive share
awards.
30 September 31 March
2021 2021
========================================================== ============= =========
Net assets per share (GBP)
Basic 11.55 9.50
Diluted 11.53 9.47
Net assets (GBPm)
Net assets attributable to equity holders of the Company 11,173 9,164
========================================================== ============= =========
30 September 31 March
2021 2021
============================================== ============= ============
Number of shares in issue
Ordinary shares 973,205,270 973,166,947
Own shares (6,205,579) (8,530,634)
============================================== ============= ============
966,999,691 964,636,313
============================================== ============= ============
Effect of dilutive potential ordinary shares
Share awards 2,251,033 2,656,230
============================================== ============= ============
Diluted shares 969,250,724 967,292,543
============================================== ============= ============
The calculation of basic earnings per share is based on the
profit attributable to shareholders and the weighted average number
of shares in issue. The weighted average shares in issue for the
period to 30 September 2021 are 966,063,483 (2020: 963,542,371).
When calculating the diluted earnings per share, the weighted
average number of shares in issue is adjusted for the effect of all
dilutive share awards. The diluted weighted average shares in issue
for the period to 30 September 2021 are 968,079,404 (2020:
964,863,213).
6 months 6 months
to 30 September to 30 September
2021 2020
===================================================================== ================ ================
Earnings per share (pence)
Basic 227.4 130.1
Diluted 226.9 130.0
Earnings (GBPm)
Profit for the period attributable to equity holders of the Company 2,197 1,254
===================================================================== ================ ================
6 Dividends
6 months to 6 months to 6 months to 6 months to
30 September 30 September 30 September 30 September
2021 2021 2020 2020
pence pence
per share GBPm per share GBPm
===================================== ============= ============= ============= ===============
Declared and paid during the period
Second dividend 21.0 203 17.5 169
===================================== ============= ============= ============= =============
21.0 203 17.5 169
===================================== ============= ============= ============= =============
Proposed first dividend 19.25 186 17.5 169
===================================== ============= ============= ============= =============
The dividend can be paid out of either the capital reserve or
the revenue reserve subject to the investment trust rules.
The distributable reserves of the parent company as at 31 March
2021 were GBP3,811 million (31 March 2020: GBP3,863 million) and
the Board reviews the distributable reserves bi-annually, including
consideration of any material changes since the most recent audited
accounts, ahead of proposing any dividend. The Board also reviews
the proposed dividends in the context of the requirements of being
an approved investment trust. Shareholders are given the
opportunity to approve the total dividend for the year at the
Company's Annual General Meeting. Details of the Group's continuing
viability and going concern can be found in the Risk management
section on pages 50 to 63 of the Annual report and accounts
2021.
7 Investment portfolio
This section should be read in conjunction with Note 11 on page
145 of the Annual report and accounts 2021, which provides more
detail about initial recognition and subsequent measurement of
investments at fair value.
6 months to Year to
30 September 2021 31 March 2021
Non-current GBPm GBPm
======================================================== ================= =============
Opening book value 5,010 3,454
Additions 32 881
- of which loan notes with nil value - (24)
Disposals, repayments and write-offs (47) (333)
Fair value movements recognised in profit or loss(1) 1,074 1,217
Other movements and net cash movements(2) 47 (185)
Closing book value 6,116 5,010
======================================================== ================= =============
Quoted investments 817 797
Unquoted investments 5,299 4,213
======================================================== ================= =============
Closing book value 6,116 5,010
======================================================== ================= =============
1 All fair value movements relate to assets held at the end of the period
and are recognised in unrealised profits on the revaluation of investments.
2 Other movements includes the impact of foreign exchange and accrued
interest.
3i's investment portfolio is made up of longer-term investments,
with average holding periods greater than one year, and thus is
classified as non-current.
Additions in the period include cash investment of GBP24 million
(31 March 2021: GBP126 million), GBP8 million (31 March 2021: GBP34
million) in capitalised interest received by way of loan notes, of
which none (31 March 2021: GBP24 million) were written down to nil
and no transfer of assets from investment entity subsidiaries (31
March 2021: GBP721 million).
In the period no transfer of assets to investment entity
subsidiaries were included within disposals, repayments and
write-offs (31 March 2021: GBP259 million).
Included within profit or loss is GBP13 million (31 March 2021:
GBP22 million) of interest income. Interest income included GBP3
million (2021: GBP10 million) of accrued income capitalised during
the period and GBP10 million (2021: GBP12 million) of accrued
income remaining uncapitalised at the period end.
Quoted investments are classified as Level 1 in the fair value
hierarchy and unquoted investments are classified as Level 3 in the
fair value hierarchy; see Note 9 for details.
8 Investments in investment entity subsidiaries
This section should be read in conjunction with Note 12 on page
146 of the Annual report and accounts 2021, which provides more
detail about accounting policies adopted, entities which are
typically investment in investment entities and the determination
of fair value.
Level 3 fair value reconciliation - investments in investment
entity subsidiaries
6 months to Year to
30 September 2021 31 March 2021
Non-current GBPm GBPm
======================================================================= ================== ==============
Opening fair value 4,905 3,936
Amounts paid to investment entity subsidiaries 50 879
Amounts received from investment entity subsidiaries (78) (281)
Fair value movement on investment entity subsidiaries 1,094 792
Transfer of portfolio investments from investment entity subsidiaries - (462)
Transfer of assets to investment entity subsidiaries 12 41
======================================================================= ================== ==============
Closing fair value 5,983 4,905
======================================================================= ================== ==============
Transfer of portfolio investments from investment entity
subsidiaries includes the transfer of investment portfolio between
investment entity subsidiaries and the Company at fair value. The
consideration for these transfers can either be cash or intra-group
receivables.
Restrictions
3i Group plc, the ultimate parent company, receives dividend
income from its subsidiaries. There are no restrictions on the
ability to transfer funds from these subsidiaries to the Group at
30 September 2021.
Support
3i Group plc provides, where necessary, ongoing support to its
investment entity subsidiaries for the purchase of portfolio
investments.
9 Fair values of assets and liabilities
This section should be read in conjunction with Note 13 on pages
147 to 149 of the Annual report and accounts 2021 which provides
more detail about accounting policies adopted, the definitions of
the three levels of fair value hierarchy, valuation methods used in
calculating fair value, and the valuation framework which governs
oversight of valuations. There have been no changes in the
accounting policies adopted or the valuation methodologies
used.
Valuation
The Group classifies financial instruments measured at fair
value according to the following hierarchy:
Level Fair value input description Financial instruments
======= ========================================================== =================================================
Level 1 Quoted prices (unadjusted) from active markets Quoted equity instruments
======= ========================================================== =================================================
Level 2 Inputs other than quoted prices included in Level 1 that Derivative financial instruments
are observable either directly (ie
as prices) or indirectly (ie derived from prices)
======= ========================================================== =================================================
Level 3 Inputs that are not based on observable market data Unquoted equity instruments and loan instruments
======= ========================================================== =================================================
The table below shows the classification of financial
instruments held at fair value into the valuation hierarchy at
30 September 2021:
30 September 2021 31 March 2021
Level Level Level Total Level Level Level Total
1 2 3 1 2 3
GBPm GBPm GBPm GBPm GBPm GBPm GBPm GBPm
============================= ====== ====== ======= ======= ====== ====== ======= =======
Assets
Quoted investments 817 - - 817 797 - - 797
Unquoted investments - - 5,299 5,299 - - 4,213 4,213
Investments in investment
entity subsidiaries - - 5,983 5,983 - - 4,905 4,905
Other financial assets - 18 40 58 - 26 35 61
Liabilities
Other financial liabilities - (1) - (1) - - - -
Total 817 17 11,322 12,156 797 26 9,153 9,976
============================= ====== ====== ======= ======= ====== ====== ======= =======
We determine that in the ordinary course of business, the net
asset value of an investment entity subsidiary is considered to be
the most appropriate to determine fair value. The underlying
portfolio is valued under the same methodology as directly held
investments, with any other assets or liabilities within investment
entity subsidiaries fair valued in accordance with the Group's
accounting policies. Note 8 details the Directors' considerations
about the fair value of the investment entity subsidiaries.
The fair values of the Group's financial assets and liabilities
not held at fair value, are not materially different from their
carrying values, with the exception of loans and borrowings. The
fair value of loans and borrowings is GBP1,169 million (31 March
2021: GBP1,161 million), determined with reference to their
published market prices. The carrying value of the loans and
borrowings is GBP975 million (31 March 2021: GBP975 million) and
accrued interest payable (included within trade and other payables)
is GBP20 million (31 March 2021: GBP13 million).
Level 3 fair value reconciliation - unquoted investments
Six months to Year to
30 September 31 March
2021 2021
GBPm GBPm
======================================================== ============= ========
Opening fair value 4,213 3,036
Additions 32 584
- of which loan notes with nil value - (24)
Disposals and repayments and write-offs (47) (333)
Fair value movements recognised in profit or loss(1) 1,054 1,135
Other movements and net cash movements(2) 47 (185)
Closing fair value 5,299 4,213
======================================================== ============= ========
1 All fair value movements relate to assets held at the end of the period
and are recognised in unrealised profits on the revaluation of investments.
2 Other movements includes the impact of foreign exchange and accrued
interest.
Unquoted investments valued using Level 3 inputs also had the
following impact on profit or loss: realised profits over value on
disposal of investment of GBP11 million (September 2020: GBP5
million), dividend income of GBP9 million (September 2020: GBP22
million) and foreign exchange gains of GBP43 million (September
2020: GBP19 million).
Assets move between Level 1 and Level 3 when an unquoted equity
investment lists on a quoted market exchange. There were no
transfers in or out of Level 3 during the period. In the six months
to 30 September 2021, two assets changed valuation basis within
level 3. One asset moved from other basis to an earnings-based
valuation and one asset moved from an earnings-based valuation to
an imminent sale basis. Action remains unchanged on an
earnings-based valuation. The changes in valuation methodology in
the period reflect our view of the most appropriate method to
determine the fair value of the two assets at 30 September 2021.
Further information can be found in the Private Equity and
Infrastructure sections of the Business and Financial review.
The following table summarises the various valuation
methodologies used by the Group to fair value level 3 instruments,
the inputs and the sensitivities applied and the impact of those
sensitives to the unobservable inputs. We have maintained a 5%
sensitivity which is appropriate given the strength in performance
of our companies. For the small number of companies in our
portfolio that operate in more challenged sectors such as travel
and automotive, our fair value at the 30 September 2021, reflects
the impact this has had on performance. All numbers in the table
below are on an investment basis.
Level 3 unquoted investments
Methodology Description Inputs Fair value at 30 Sensitivity on key unobservable input Fair value impact of
September 2021 (GBPm) sensitivities (GBPm)
+5%/-5%
Earnings (Private Equity) Most commonly used Private Equity valuation methodology. Earnings multiples are applied to the earnings of the company to determine the enterprise 10,337 For the assets valued on an earnings basis, we have applied a 5% sens 618
value itivity to the earnings
multiple
Used for investments which are typically profitable and for which we can determine a set of Earnings multiples (31 March 2021: 8,393) (31 March 2021: 528)
listed companies and precedent transactions, where relevant, with similar characteristics.
When selecting earnings multiple, we consider:
1. Comparable listed companies' current performance and through the cycle averages.
2. Relevant market transaction multiples.
3. Exit expectations and other company specific factors (628)
For point 1 and 2 of the above we select companies in the same industry and, where possi (31 March 2021: (539)
ble,
with a similar business model and profile in terms of size, products, services and custo
mers,
growth rates and geographic focus.
The pre-discount multiple ranges from 8.5x-19.5x (31 March 2021: 8.5x - 19.5x). Action is our largest asset, and we have included a 5% sensitivity
on Action's earnings multiple
of 19.5x (equivalent to 18.5x net). On a stand-alone basis, this is
equal to
354
(31 March 2021: 283)
(355)
(31 March 2021: (284))
-------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------------- ------------------------
Other inputs:
Earnings
Reported earnings are adjusted for non-recurring items, such as restructuring expenses,
for
significant corporate actions and, in exceptional cases, run-rate adjustments to arrive
at
maintainable earnings.
The most common measure is earnings before interest, tax, depreciation and amortisation
("EBITDA").
Earnings are usually obtained from portfolio company management accounts to the preceding
quarter end, with reference also to forecast earnings and the maintainable view of
earnings.
Action, our largest asset, we value using run-rate earnings.
-------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------------- ------------------------
Discounted cash flow (Private Equity/ Infrastructure/ Scandlines) Appropriate for businesses with long-term stable cash flows, typically in Infrastructure or Long-term cash flows are discounted at a rate which is benchmarked against market data, w 885 For the assets valued on a DCF basis, we have applied a 5% sensitivit (35)
alternatively businesses where DCF is more appropriate in the short term. here y to the discount rate
possible, or adjusted from the rate at the initial investment based on changes in the ris
k
profile of the investment.
(31 March 2021: 831) (31 March 2021: (38))
37
(31 March 2021: 40)
-------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------------- ------------------------
Imminent sale (Private Equity) Used for assets where a sale has been agreed. A 2.5% discount is applied to expected proceeds net of fees. 343 n/a n/a
(31 March 2021: -)
-------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------------- ------------------------
NAV (Private Equity/Infrastructure) Used for investments in unlisted funds. Net asset value reported by the fund manager. The valuation of the underlying portfolio i 73 A 5% increase on closing NAV 4
s
consistent with IFRS.
(31 March 2021: 69) (31 March 2021: 3)
-------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------------- ------------------------
Other (Private Equity/Infrastructure) Used where elements of a business are valued on different bases. Values of separate elements prepared on one of the methodologies listed above. 68 A 5% increase in the closing value 3
(31 March 2021: 104) (31 March 2021: 5)
-------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------- ------------------------ --------------------------------------------------------------------- ------------------------
10 Related parties
All related party transactions that took place in the six months
ending 30 September 2021 are consistent in nature with the
disclosures in Note 29 on pages 164 to 166 of the Annual report and
accounts 2021. Related party transactions which took place in the
period and materially affected performance or the financial
position of the Group, together with any material changes in
related party transactions as described in the Annual report and
accounts 2021 that could materially affect the performance or the
financial position of the Group are detailed below.
Investments
The Group makes investments in the equity of unquoted and quoted
investments where it does not have control but may be able to
participate in the financial and operating policies of that
company. IFRS presumes that it is possible to exert significant
influence when the equity holding is greater than 20%. The Group
has taken the investment entity exception as permitted by IFRS 10
and has not equity accounted for these investments, in accordance
with IAS 28, but they are related parties. The total amounts
included for investments where the Group has significant influence
but not control are as follows:
Consolidated statement of comprehensive income Six months to Six months to
30 September 30 September
2021 2020
GBPm GBPm
============================================================= ============== ==============
Realised profits over value on the disposal of investments 1 5
Unrealised profits on the revaluation of investments 87 67
Portfolio income 6 9
============================================================= ============== ==============
Consolidated statement of financial position 30 September 31 March
2021 2021
GBPm GBPm
============================================== ============= =========
Unquoted investments 664 578
---------------------------------------------- ------------- ---------
Management arrangements
The Group acted as Investment Manager to 3i Infrastructure plc
("3iN"), which is listed on the London Stock Exchange, for the
period to 30 September 2021. The following amounts have been
recognised in respect of the management relationship:
Consolidated statement of comprehensive income Six months to Six months to
30 September 30 September
2021 2020
GBPm GBPm
====================================================== ============== ==============
Unrealised profits on the revaluation of investments 20 71
Dividends 13 8
Fees receivable from external funds 16 12
====================================================== ============== ================
Consolidated statement of financial position 30 September 31 March
2021 2021
GBPm GBPm
Quoted equity investments 817 797
Performance fees receivable - 8
Statement of Directors' responsibilities
The Directors, who are required to prepare the financial
statements on a going concern basis unless it is not appropriate,
are satisfied that the Group has the resources to continue in
business for the foreseeable future. In making this assessment, the
Directors have considered information relating to present and
future conditions, including future projections of profitability
and cash flows .
The Directors confirm that to the best of their knowledge:
a) the condensed set of financial statements has been prepared
in accordance with IAS 34 "Interim Financial Reporting" as adopted
for use in the UK; and
b) the Half-year report includes a fair review of the
information required by:
i) DTR 4.2.7R of the Disclosure Guidance and Transparency Rules,
being an indication of important events that have occurred during
the first six months of the financial year ending 31 March 2022
and their impact on the condensed set of financial statements;
and a description of the principal risks and uncertainties for
the remaining six months of the financial year; and
ii) DTR 4.2.8R of the Disclosure Guidance and Transparency Rules,
being (i) related party transactions that have taken place in
the first six months of the financial year ending 31 March 2022
which have materially affected the financial position or performance
of 3i Group during that period; and (ii) any changes in the related
party transactions described in the Annual report and accounts
2021 that could materially affect the financial position or performance
of 3i Group during the first six months of the financial year
ending 31 March 2022.
The Directors of 3i Group plc and their functions are listed
below.
The report is authorised for issue by order of the Board.
K J Dunn , Secretary
10 November 2021
List of Directors and their functions
The Directors of the Company and their functions are listed
below:
Simon Thompson, Chairman and Chairman of the Nominations
Committee
Simon Borrows, Chief Executive and Executive Director
Julia Wilson, Group Finance Director and Executive Director
Caroline Banszky, non-executive Director and Chairman of the
Audit and Compliance Committee
Stephen Daintith, non-executive Director
David Hutchison, non-executive Director, Senior Independent
Director and Chairman of the Valuations Committee
Lesley Knox, non-executive Director
Coline McConville, non-executive Director and Chairman of the
Remuneration Committee
Peter McKellar, non-executive Director
Alexandra Schaapveld, non-executive Director
Independent review report to 3i Group plc
Conclusion
We have been engaged by the Company to review the condensed set
of financial statements in the half-yearly financial report for the
six months ended 30 September 2021 which comprises the Condensed
consolidated statement of comprehensive income, the Condensed
consolidated statement of financial position, the Condensed
consolidated statement of changes in equity, the Condensed
consolidated cash flow statement and the related explanatory
notes.
Based on our review, nothing has come to our attention that
causes us to believe that the condensed set of financial statements
in the half-yearly financial report for the six months ended 30
September 2021 is not prepared, in all material respects, in
accordance with UK adopted international accounting standards and
the Disclosure Guidance and Transparency Rules ("the DTR") of the
UK's Financial Conduct Authority ("the UK FCA").
Scope of review
We conducted our review in accordance with International
Standard on Review Engagements (UK and Ireland) 2410 Review of
Interim Financial Information Performed by the Independent Auditor
of the Entity issued by the Auditing Practices Board for use in the
UK. A review of interim financial information consists of making
enquiries, primarily of persons responsible for financial and
accounting matters, and applying analytical and other review
procedures. We read the other information contained in the
half-yearly financial report and consider whether it contains any
apparent misstatements or material inconsistencies with the
information in the condensed set of financial statements.
A review is substantially less in scope than an audit conducted
in accordance with International Standards on Auditing (UK) and
consequently does not enable us to obtain assurance that we would
become aware of all significant matters that might be identified in
an audit. Accordingly, we do not express an audit opinion.
Directors' Responsibilities
The half-yearly financial report is the responsibility of, and
has been approved by, the directors. The directors are responsible
for preparing the half-yearly financial report in accordance with
the DTR of the UK FCA.
As disclosed in 'Basis of preparation and accounting policies',
the annual financial statements of the group are prepared in
accordance with UK adopted international accounting standards. The
directors are responsible for preparing the condensed set of
financial statements included in the half-yearly financial report
in accordance with IAS 34 as adopted for use in UK.
Our Responsibility
Our responsibility is to express to the company a conclusion on
the condensed set of financial statements in the half-yearly
financial report based on our review.
The purpose of our review work and to whom we owe our
responsibilities
This report is made solely to the company in accordance with the
terms of our engagement to assist the company in meeting the
requirements of the DTR of the UK FCA. Our review has been
undertaken so that we might state to the company those matters we
are required to state to it in this report and for no other
purpose. To the fullest extent permitted by law, we do not accept
or assume responsibility to anyone other than the company for our
review work, for this report, or for the conclusions we have
reached.
Jonathan Mills
For and on behalf of KPMG LLP
Chartered Accountants
15 Canada Square
London
E14 5GL
10 November 2021
Portfolio and other information
20 large investments
The 20 investments listed below account for 95 % of the
portfolio value at 30 September 2021 (31 March 2021: 95%).
Residual Residual
Business line cost(1) cost(1) Valuation Valuation
Geography September March September March
Investment First invested in 2021 2021 2021 2021 Relevant transactions
Description of Valuation basis GBPm GBPm GBPm GBPm in the period
business
Action* Private Equity 623 623 6,100 4,566
General merchandise Netherlands
discount retailer 2011/2020
Earnings
3i Infrastructure plc* Infrastructure 305 305 817 797
Quoted investment UK
company, investing 2007
in infrastructure Quoted
Cirtec Medical* Private Equity 172 172 488 444 Acquisition of
Outsourced medical US Cardea in July 2021
device manufacturing 2017
Earnings
Scandlines Scandlines 529 529 469 435
Ferry operator between Denmark/Germany
Denmark and Germany 2018
DCF
Luqom* Private Equity 169 110 453 307 Acquisition of
Online lighting Germany Lampemesteren
specialist
retailer 2017 in April 2021
Earnings GBP57 million further
investment in July
2021
Tato Private Equity 2 2 412 368
Manufacturer and UK
seller of
speciality chemicals 1989
Earnings
Magnitude Software* Private Equity 139 139 343 165 Sale agreed in
Provider of unified US September 2021
application data 2019 and completed in
management solutions Imminent sale November 2021
Hans Anders* Private Equity 268 268 323 262
Value-for-money Netherlands
optical
retailer 2017
Earnings
Royal Sanders* Private Equity 136 136 295 364 Distributed
Private label and Netherlands GBP84 million to 3i
contract in
manufacturing producer 2018 June 2021
of
personal care products Earnings
Evernex* Private Equity 278 272 283 281
Provider of France
third-party
maintenance services 2019
for
data centre Earnings
infrastructure
WP* Private Equity 230 222 265 259
Supplier of plastic Netherlands
packaging solutions 2015
Earnings
Havea* Private Equity 191 187 265 242 Acquisition
Manufacturer of France of ixX Pharma in
natural
healthcare and 2017 September 2021
cosmetics
products Earnings
Basic-Fit Private Equity 23 23 261 214
Discount gyms operator Netherlands
2013
Quoted
Q Holding* Private Equity 162 162 254 187
Manufacturer of US
precision
engineered elastomeric 2014
components Earnings
AES Engineering Private Equity 30 30 254 212
Manufacturer of UK
mechanical
seals and support 1996
systems
Earnings
BoConcept* Private Equity 167 165 240 161 Distributed GBP17
Urban living designer Denmark million to 3i in
2016 July 2021
Earnings
SaniSure* Private Equity 76 135 189 183 Returned GBP59
Manufacturer, US million of
distributor
and
integrator of 2019 funding to 3i in
single-use
bioprocessing systems Earnings July 2021
and
components
Smarte Carte* Infrastructure 181 176 170 160
Provider of US
self-serve
vended luggage carts, 2017
electronic lockers DCF
and
concession carts
MPM* Private Equity 133 128 149 124
An international UK
branded,
premium and natural 2020
pet
food company Earnings
Regional Rail* Infrastructure 175 175 140 131
Owns and operates US
short-line freight 2019
railroads
and rail-related DCF
businesses
3,989 3,959 12,170 9,862
* Controlled in accordance with IFRS.
1 Residual cost includes cash investment and interest net of
cost disposed.
Glossary
2013-2016 vintage includes Aspen Pumps, Audley Travel,
Basic-Fit, Dynatect, Kinolt, ATESTEO, JMJ, Q Holding, WP,
Scandlines further (completed in December 2013), Christ, Geka,
Óticas Carol and Blue Interactive.
2016-2019 vintage includes BoConcept, Cirtec Medical, Formel D,
Hans Anders, arrivia, Luqom, Magnitude Software, Havea, Royal
Sanders and Schlemmer.
2019-2022 vintage includes Evernex, SaniSure, GartenHaus, MPM,
WilsonHCG, ten23 Health and MAIT.
Approved Investment Trust Company This is a particular UK tax
status maintained by 3i Group plc, the parent company of 3i Group.
An approved Investment Trust company is a UK company which meets
certain conditions set out in the UK tax rules which include a
requirement for the company to undertake portfolio investment
activity that aims to spread investment risk and for the company's
shares to be listed on an approved exchange. The "approved" status
for an investment trust must be agreed by the UK tax authorities
and its benefit is that certain profits of the company, principally
its capital profits, are not taxable in the UK.
Assets under management ("AUM") A measure of the total assets
that 3i has to invest or manages on behalf of shareholders and
third-party investors for which it receives a fee. AUM is measured
at fair value. In the absence of a third-party fund in Private
Equity, it is not a measure of fee generating capability.
Board The board of Directors of the Company.
Buyouts 2010-2012 vintage includes Action, Amor, Element,
Etanco, Hilite, OneMed and Trescal.
Capital redemption reserve is established in respect of the
redemption of the Company's ordinary shares.
Capital reserve recognises all profits that are capital in
nature or have been allocated to capital. Following changes to the
Companies Act, the Company amended its Articles of Association at
the 2012 Annual General Meeting to allow these profits to be
distributable by way of a dividend.
Carried interest payable is accrued on the realised and
unrealised profits generated taking relevant performance hurdles
into consideration, assuming all investments were realised at the
prevailing book value. Carried interest is only actually paid when
the relevant performance hurdles are met and the accrual is
discounted to reflect expected payment periods.
Carried interest receivable The Group earns a share of profits
from funds which it manages on behalf of third parties. These
profits are earned when the funds meet certain performance
conditions and are paid by the fund once these conditions have been
met on a cash basis. The carried interest receivable may be subject
to clawback provisions if the performance of the fund deteriorates
following carried interest being paid.
Company 3i Group plc.
DACH The region covering Austria, Germany and Switzerland.
Discounting The reduction in present value at a given date of a
future cash transaction at an assumed rate, using a discount factor
reflecting the time value of money.
EBITDA is defined as earnings before interest, taxation,
depreciation and amortisation and is used as the typical measure of
portfolio company performance.
EBITDA multiple Calculated as the enterprise value over EBITDA,
it is used to determine the value of a company.
Fair value movements on investment entity subsidiaries The
movement in the carrying value of Group subsidiaries, classified as
investment entities under IFRS 10, between the start and end of the
accounting period converted into sterling using the exchange rates
at the date of the movement.
Fair value through profit or loss ("FVTPL") is an IFRS
measurement basis permitted for assets and liabilities which meet
certain criteria. Gains and losses on assets and liabilities
measured as FVTPL are recognised directly in the Statement of
comprehensive income.
Fee income (or Fees receivable) is earned for providing services
to 3i's portfolio companies and predominantly falls into one of two
categories. Negotiation and other transaction fees are earned for
providing transaction related services. Monitoring and other
ongoing service fees are earned for providing a range of services
over a period of time.
Fees receivable from external funds Fees receivable from
external funds are earned for providing management and advisory
services to a variety of fund partnerships and other entities. Fees
are typically calculated as a percentage of the cost or value of
the assets managed during the year and are paid quarterly, based on
the assets under management to date.
Foreign exchange on investments arises on investments made in
currencies that are different from the functional currency of the
Group entity. Investments are translated at the exchange rate
ruling at the date of the transaction. At each subsequent reporting
date investments are translated to sterling at the exchange rate
ruling at that date.
Gross investment return ("GIR") includes profit and loss on
realisations, increases and decreases in the value of the
investments we hold at the end of a period, any income received
from the investments such as interest, dividends and fee income,
movements in the fair value of derivatives and foreign exchange
movements. GIR is measured as a percentage of the opening portfolio
value.
Growth 2010-2012 vintage includes Element, Hilite, BVG, Go
Outdoors, Loxam, Touchtunes and WFCI.
Interest income from investment portfolio is recognised as it
accrues. When the fair value of an investment is assessed to be
below the principal value of a loan, the Group recognises a
provision against any interest accrued from the date of the
assessment going forward until the investment is assessed to have
recovered in value.
International Financial Reporting Standards ("IFRS") are
accounting standards issued by the International Accounting
Standards Board ("IASB"). The Group's consolidated financial
statements are required to be prepared in accordance with IFRS.
Investment basis Accounts prepared assuming that IFRS 10 had not
been introduced. Under this basis, we fair value portfolio
companies at the level we believe provides the most comprehensive
financial information.
IRR Internal Rate of Return.
Key Performance Indicator ("KPI") is a measure by reference to
which the development, performance or position of the Group can be
measured effectively.
Like-for-like figures compare financial results in one period
with those for the previous perio d.
Money multiple is calculated as the cumulative distributions
plus any residual value divided by paid-in capital.
Net asset value ("NAV") is a measure of the fair value of our
proprietary investments and the net costs of operating the
business.
Operating cash profit/loss is the difference between our cash
income (consisting of portfolio interest received, portfolio
dividends received, portfolio fees received and fees received from
external funds as per the Investment basis Consolidated cash flow
statement) and our operating expenses and lease payments (as per
the Investment basis Consolidated cash flow statement).
Operating profit includes gross investment return, management
fee income generated from managing external funds, the costs of
running our business, net interest payable, other losses and
carried interest.
Organic growth is the growth a company achieves by increasing
output and enhancing sales internally.
Performance fee receivable The Group earns a performance fee
from the investment management services it provides to 3i
Infrastructure plc ("3iN") when 3iN's total return for the year
exceeds a specified threshold. This fee is calculated on an annual
basis and paid in cash early in the next financial year.
Portfolio income is that which is directly related to the return
from individual investments. It is comprised of dividend income,
income from loans and receivables and fee income.
Proprietary Capital Shareholders' capital which is available to
invest to generate profits.
Realised profits or losses over value on the disposal of
investments The difference between the fair value of the
consideration received, less any directly attributable costs, on
the sale of equity and the repayment of loans and receivables and
its carrying value at the start of the accounting period, converted
into sterling using the exchange rates at the date of disposal.
Revenue reserve recognises all profits that are revenue in
nature or have been allocated to revenue.
Segmental reporting Operating segments are reported in a manner
consistent with the internal reporting provided to the Chief
Executive who is considered to be the Group's chief operating
decision maker. All transactions between business segments are
conducted on an arm's length basis, with intrasegment revenue and
costs being eliminated on consolidation. Income and expenses
directly associated with each segment are included in determining
business segment performance.
Share-based payment reserve is a reserve to recognise those
amounts in retained earnings in respect of share-based
payments.
Syndication The sale of part of our investment in a portfolio
company to a third party, usually within 12 months of our initial
investment and for the purposes of facilitating investment by a
co-investor or portfolio company management in line with our
original investment plan. A syndication is treated as a negative
investment rather than a realisation.
Total return comprises of operating profit less tax charge less
movement in actuarial valuation of the historic defined benefit
pension scheme.
Total shareholder return ("TSR") is the measure of the overall
return to shareholders and includes the movement in the share price
and any dividends paid, assuming that all dividends are reinvested
on their ex -- dividend date.
Translation reserve comprises all exchange differences arising
from the translation of the financial statements of international
operations.
Unrealised profits or losses on the revaluation of investments
The movement in the carrying value of investments between the start
and end of the accounting period converted into sterling using the
exchange rates at the date of the movement.
Information for shareholders
Note
The first FY2022 dividend is expected to be paid on 12 January
2022 to holders of ordinary shares on the register on 3 December
2021. The ex-dividend date will be 2 December 2021.
3i Group plc
Registered office:
16 Palace Street,
London SW1E 5JD, UK
Registered in England No. 1142830
An investment company as defined by section 833 of the Companies
Act 2006.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IR EAEFEFENFFAA
(END) Dow Jones Newswires
November 11, 2021 02:00 ET (07:00 GMT)
3i (LSE:III)
Historical Stock Chart
From Apr 2024 to May 2024
3i (LSE:III)
Historical Stock Chart
From May 2023 to May 2024